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Background 
This general introduction will elaborate on the physiological characteristics of intestinal 
integrity and permeability. Specific attention will be paid to the digestion and absorption of 
protein. Subsequently, the two approaches to study intestinal integrity as applied in this 
thesis, an in vivo human intervention model and an in vitro human cell model, will be 
introduced. Finally, the aims and outline of this thesis will be given.  
In advance, I would like to emphasize the importance of the gut in human wellbeing; this 
organ plays a pivotal role in the maintenance of homeostasis and health. Many physiological 
and pathophysiological conditions can cause dysregulation of the integrity of the epithelial 
barrier. Examples are autoimmune diseases (T1D, MS, etc.) [1], food allergies [2], diseases 
related to the gut (Celiac Disease, Crohn’s Disease, etc.) [3, 4], and diseases related to 
chronic inflammation (IBD, chronic fatigue syndrome, etc.) [5, 6], but also physiological 
conditions such as strenuous physical exercise [7, 8], psychological stress [9] and the use of 
alcohol or specific medication (non-steroid anti-inflammatory drugs, NSAIDs) [10-12] have 
been implicated in dysregulation of intestinal integrity. In order to find potential mitigation 
strategies to support the integrity of the intestinal barrier, it is important to define intestinal 
barrier integrity and to determine possible mechanisms underlying its dysregulation. 
The gut serves two major functions to support whole body homeostasis and health. First it is 
the site for the digestion of food and subsequent absorption of water, minerals, and 
nutrients and second it protects the body’s internal environment from potentially harmful 
compounds and micro-organisms in the external environment. Therefore, the small intestine 
has to form a selective semi-permeable barrier with a high capacity of digestion, absorption 
and metabolism of essential dietary nutrients, while, at the same time, it has to prevent the 
invasion of potentially harmful dietary and microbial antigens and commensal and 
pathogenic bacteria and toxins. When this epithelial barrier functions in a proper manner, 
the integrity of the intestinal barrier is high. Dysregulation of this integrity of the epithelial 
barrier can lead to an increase in intestinal permeability and translocation of potentially 
harmful compounds, which contributes to local and systemic immune activation [13]. 
Thesis aim:  
To characterise intestinal permeability to dietary 
proteins and peptides in vivo and in vitro. 
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Intestinal integrity 
Intestinal integrity refers to the two key features essential for maintaining intestinal barrier 
function. These are, first, the physical and biochemical epithelial barrier, and second the 
intestinal immune system. The physical and biochemical barrier of the intestine consists of a 
polarized monolayer of intestinal epithelial cells, also named enterocytes, covered by a 
continuous mucus layer. These enterocytes are rapidly renewed, with high rates of 
differentiation and shedding. The enterocytes are held together by three different 
interconnected protein networks: desmosomes, adherens junctions, and tight junctions 
(Figure 1.1). Together, these networks are called junctional complexes [14]. These junctional 
complexes interact with neighbouring cells, and are therefore of importance to facilitate 
intercellular communication. They are furthermore connected with the cytoskeleton and are 
thereby also of importance to preserve the epithelial architecture and to facilitate cell 
migration during epithelial cell turnover [15, 16]. 
 
 
Figure 1.1. Intercellular junctions between and transport routes across intestinal epithelial cells 
The intercellular space between intestinal epithelial cells is sealed by different protein complexes, including 
tight junctions, adherens junctions, and desmosomes. The adherence junctions and desmosomes provide 
strong adhesive bonds between the epithelial cells and support intercellular communication, but they do not 
determine paracellular permeability. The tight junctions consist of transmembrane proteins and intracellular 
proteins connected to the actin cytoskeleton, creating a selective barrier for the paracellular transport 
pathway. This figure was produced using Servier Medical Art. (http://www.servier.com). 
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Nutrients and other compounds can cross the epithelial barrier via transcellular and 
paracellular routes (Figure 1.1). The transcellular route (through the enterocyte) is mainly 
used to absorb water and nutrients [17, 18]. The paracellular route (in between the 
enterocyte) is facilitated by the paracellular space surrounding the brush border surface of 
the enterocytes. The size of this paracellular space is particularly determined by the before 
mentioned junction complexes [14]. These complexes are important regulators of the 
paracellular pathway and allow the passage of water, solutes, and ions, but under normal 
conditions prevent the absorption of larger nutrients, such as peptides and protein-sized 
molecules[19, 20]. The tight junctions limit the flux of solutes and hence are considered the 
rate-limiting step in the paracellular route of transport [21]. The tight junctions are highly 
dynamic complexes, continuously monitored and regulated by signalling molecules [22]. 
Many different protein families form these highly dynamic complexes which anchor two 
neighbouring enterocytes, such as zonula occludens, occludins, claudins, and junctional 
adhesion molecules. Each of these protein families has a specific function with regard to the 
regulation of intestinal permeability. The claudin family is the main determinant of 
regulation of paracellular permeability by the tight junctions [23]. Some of these claudins 
play a role in decreasing the paracellular permeability by tightening the junctions, examples 
are claudin 1, 4, 5, and 8 [24-27]. In contrast, claudin 2, 7, and 12 have been described to 
increase paracellular permeability [28-30], for example by forming water pores accessible for 
cations [28]. The structure and function of the different tight junction proteins have been 
extensively reviewed by Suzuki et al. [21]. 
Digestion and absorption of dietary protein 
Characteristics of the gastrointestinal tract for the digestion and absorption of dietary 
proteins have been described since the late 1970s, but detailing these processes is ongoing 
[31]. 
Digestion of dietary proteins starts in the stomach under the influence of gastric acid and 
pepsinogens secreted by the chief cells of the gastric gland. Gastric acid not only aids to 
denature protein, it also lowers the pH. This converts the inactive pepsinogen into the active 
pepsin. Proteins denatured by the low pH alter their conformational structure, which makes 
their peptide bonds readily accessible for pepsin. Pepsin cleaves the dietary protein at 
specific points of the peptide chains, preferably between hydrophobic and aromatic amino 
acid residues, into polypeptides. Once the now partially hydrolysed protein enters the small 
intestine, digestion is taken over by proteases excreted by the pancreas. Trypsin, 
chymotrypsin, elastase, and carboxypeptidases cleave the polypeptides into oligopeptides, 
tripeptides, dipeptides, and single amino acids. Each of these proteases has its own 
specificity. Endopeptidases cleave the peptide chains at the peptide bonds of specific amino 
acids, while exopeptidases cleave specific amino acids one at the time from the carboxyl end 
of the peptide chains. Additionally, the brush border contains aminopeptidases which 
further cleave amino acids from the amino end of the peptide chains. Some proteins or 
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protein-derived peptides are relatively resistant to digestion due to their structural features. 
For example, proteins that contain many disulphide bonds are resistant to denaturation by 
the gastric low pH [32]. Without this denaturation step, cleavage sites for the digestive 
enzymes are much less accessible for cleavage. Next to this, due to the different specificities 
of each of the digestive enzymes, some proteins and peptides are more difficult to cleave 
than others and this is especially true when they are not denatured. Examples of proteins 
and peptides where their bioactivity and immunogenicity depend on their partial resistance 
to digestion are food allergens and bioactive peptides [33]. The bioactive peptides resulting 
from partial protein digestion have amino acid sequences relatively resistant to the action of 
the digestive enzymes; the sequences contain for example several proline residues [34]. For 
that reason they can be absorbed intactly and execute their bioactive properties 
systemically, which may, for example, be anti-hypertensive effects. The bioactivity of a large 
number of peptides has been described for partially digested proteins, such as milk proteins 
[35]. 
 
After the dietary proteins have been broken down by digestive enzymes to oligopeptides, tri- 
and dipeptides and free amino acids, these have to be absorbed by the enterocytes. Of the 
two main routes for the absorption of nutrients across the epithelial barrier (Figure 1.1), the 
transcellular route through the epithelial cells is a collection of three different mechanisms 
of transport: (1) passive diffusion, (2) active and passive, carrier-mediated transport, and (3) 
endocytosis and exocytosis [36]. The first does not seems to play a role in the absorption of 
peptides and amino acids, but there are many different amino acid transporters [31] with 
affinities for different types of amino acids and with different types of active and passive 
transport. The di/tripeptide transporter (PEPT1) is the major transporter accountable for the 
absorption of oligopeptides across the enterocytes. Endocytosis and exocytosis play a role in 
the absorption of peptides and possibly even intact proteins [37]. Immediately after birth, 
relative large quantities of larger peptides are absorbed across the intestinal epithelial 
barrier. This absorption of larger peptides or intact protein transfers passive immunity from 
mother to child and is suggested to discontinue several months after birth after closure of 
the gut [38, 39]. 
 
The question whether larger peptides or intact proteins are absorbed also in adult healthy 
life is an intriguing one. Gardner [40, 41] already discussed upon this topic, but there is still 
limited evidence that larger peptides and protein are taken up intactly by the intestine [42, 
43]. From the existence of food allergies, however, it can be deduced that indeed a small 
amount of immunologically active food protein can be taken up and enter the circulation 
[44]. In this thesis, I will examine whether this also applies for several specifically chosen 
dietary proteins and peptides and whether a physiological challenge, in this case exercise, 
can affect this uptake.  
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Intestinal permeability- the definition 
I would like to use this paragraph to clearly define the expression ‘intestinal permeability’ as 
it will be applied throughout this thesis. Definitions in literature are not always clear and 
often intestinal permeability refers only to the ability of compounds to cross the intestinal 
epithelial barrier via the paracellular route [45]. The focus in this thesis will be on intact 
peptides and proteins, which are, under normal conditions, crossing the intestinal epithelial 
barrier only to a very minor extent. I would like to simplify the definition of intestinal 
permeability to: ‘the ability of compounds to cross the intestinal epithelial barrier’, 
independent of the route involved (Figure 1.2).  
 
 
Figure 1.2. Schematic overview of the definition of intestinal permeability. 
This scheme explains the definition of intestinal permeability as applied in this thesis and shows the different 
factors, transcellular transport and intestinal integrity, which can influence intestinal permeability. Intestinal 
integrity is determined by the cell integrity, which can decrease with the loss of cells, and the tight junctions, 
which determine paracellular transport. 
 
The main reason for this simplification is that in the studies performed within this thesis, the 
cause for changes in the amount of a specific dietary protein that crosses the intestinal 
epithelial barrier is not directly determined. There are several ways in which dietary proteins 
can cross the intestinal epithelial barrier to a greater extent when this barrier is 
physiologically challenged. First, there could be increased transcellular transport and second, 
compromised intestinal integrity could lead to increased leakage of the dietary proteins. The 
latter could be due to epithelial cell loss and thus changes in cell integrity or due to changes 
in the tight junctions which regulate paracellular transport. Because I cannot directly 
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distinguish between these different causes in the in vivo studies, it is important to take 
established markers for each of these factors into account. 
Intestinal permeability in vivo 
Specific inert markers of different sizes are used to determine the ability of compounds to 
cross the epithelial barrier via the paracellular and transcellular route. The sugar test is most 
frequently used in the in vivo human situation [46]. This test has already been developed 
and applied from the 1970s [47, 48], mainly to assess the leaky gut in intestine-related 
diseases. Sugar tests consist of one or more inert sugars. When the dual sugar test is applied, 
this contains one monosaccharide suggested to freely move across the small intestine via 
the transcellular pathway, such as mannitol or rhamnose, and one disaccharide suggested to 
be able to cross the intestinal epithelial barrier only via the paracellular pathway, such as the 
disaccharide lactulose [48, 49]. The use of two sugars instead of just one is suggested to 
correct for potential inter-individual differences such as in intestinal transit and renal 
clearance [48], although only using disaccharide-to-monosaccharide ratios could also lead to 
wrong conclusions and underestimation of intestinal permeability [50]. More recently, multi-
sugar assays containing 3-5 different inert sugars have been developed to take into account 
gastric and/or colon permeability, in addition to small intestinal permeability [51, 52], or to 
test for more different types of intestinal transport [53]. 
Exercise and intestinal permeability 
In this thesis, the main focus will be on the effects of a physiological challenge, in this case 
exercise, to induce intestinal permeability to dietary proteins and peptides. The processes 
involved in intestinal digestion, absorption and metabolism mainly take place during rest. 
During exercise, there is a shift in the blood flow from the gastrointestinal tract towards the 
muscle, which is in high need of nutrients and oxygen under exercise circumstances [54, 55]. 
Because blood flow is redistributed towards active muscles and lungs, less oxygen and 
energy substrates are available for the gastrointestinal tract. This has been reported to lead 
to various gastrointestinal complaints. The effects resulting from the reduced splanchnic 
blood flow have been shown to lead to exercise-induced intestinal permeability, which has 
been studied in several human intervention studies [7, 55-65].  
Intestinal permeability in vitro 
Many different in vivo and in vitro methods have been applied to study the small intestinal 
epithelial barrier function in humans, such as animal models, everted gut sac, isolated 
intestinal segments, Ussing chambers, and cultured cell lines. Most of these are based on 
animals or animal-derived materials. Within this thesis I have chosen to use a human cell line 
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culture, next to the human intervention studies. In vivo models are the best representation 
of the actual complex physiological situation, but in vitro models enable the study of specific 
cellular mechanisms and can be developed into relatively cheap and quick models that can 
be used for example for screening purposes. There are different human cell lines that are 
used to model the small intestinal epithelium. The most well-known cell lines are HT-29, T84, 
and Caco-2 cells. Caco-2 cells are the most frequently used cellular models to study intestinal 
epithelial permeability [66, 67]. Caco-2 cells can spontaneously differentiate into polarised 
intestinal cells in culture [68, 69]. Even though they are derived from a colon 
adenocarcinoma, upon differentiation they show many characteristics of small intestinal 
enterocytes [68, 69]. They have the ability to differentiate into a polarized monolayer on 
microporous filters after which they form domes, and present tight junctions and an apical 
brush border with its associated hydrolases, such as sucrase-isomaltase. In that respect, the 
Caco-2 cells gain favour over the other human colon carcinoma cell lines to study small 
intestinal digestion and absorption. The main advantage of HT-29 cells, however, is that this 
cell line has goblet cell phenotypic clones that are able to excrete mucus upon 
differentiation [69, 70]. Therefore, co-cultures between Caco-2 cells and HT-29 cells have 
also been applied, mainly in the field of drug transport [71]. Caco-2 cell monolayers provide 
different routes of transcellular transport as well as paracellular transport and thus 
represent the two main routes of nutrient transport [72]. 
 
In this thesis, I questioned the importance of mitochondrial oxidative metabolism for 
maintenance of intestinal integrity using differentiated Caco-2 cell monolayers. 
Mitochondrial dysfunction has been associated with intestine-related diseases such as 
inflammatory bowel disease [73], in which intestinal permeability is one of the key features. 
Caco-2 cells, however, are usually cultured in high glucose culture media. This culture 
condition, unlike the in vivo situation, facilitates survival of Caco-2 cells on glycolytic 
metabolism and hampers the study of the potential role of the mitochondria in intestinal 
permeability. This is due to the so-called ‘crabtree’ effect, which is defined as an inhibition of 
mitochondrial oxidative phosphorylation due to enhanced glycolysis [74]. Even though the 
mitochondria are functionally completely intact, stimulation of these cells with 
mitochondrial inhibitors has little effect on their energy status [75]. Cells can be cultured in 
glucose-depleted media to overcome this effect. The replacement of glucose with galactose 
has been shown to enhance mitochondrial oxidative phosphorylation in different cell types 
[75-78]. In this thesis, I tested if this also holds true for Caco-2 cells. 
Intestinal permeability of the polarized Caco-2 monolayers can be evaluated by measuring 
transepithelial resistance and/or the assessment of fluxes of marker molecules such as 
mannitol, dextrans, and inulin [21, 49, 79, 80]. The principal of the fluxes of marker 
molecules is similar to the sugar test in vivo. The transepithelial resistance reflects the ion 
flux through the paracellular space and is less determined by the size of the paracellular 
space [81]. 
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Aims and outline of this thesis 
In view of increased use of novel food sources and the prevalence of food allergies, it is 
important to understand how intestinal permeability to dietary proteins and peptides can be 
affected by normal physiological challenges, such as exercise, and to understand the 
underlying mechanisms involved. 
Therefore, the overall aim of this thesis was to characterise intestinal permeability to dietary 
proteins and peptides in vivo and in vitro. To this end, two different exercise interventions 
are evaluated, with two different populations and two different protein sources. Next, an in 
vitro intestinal epithelial Caco-2 cell model was developed to study the role of mitochondrial 
oxidative metabolism in maintenance of intestinal integrity. 
 
Chapter 2 describes the first of those exercise interventions, which was incorporated in the 
Protégé study. In this study, I compared the effect of the exercise intervention on the 
intestinal paracellular permeability by comparing the passage of lactulose with that of 
casein, as measured by the urinary accumulation of a casein-derived peptide, 
betacasomorphin-7. Within this study, many stress-related parameters of exercise were 
analysed as well. As it was chosen to design the Protégé study in such a way that well-
trained healthy male cyclists completed the exercise intervention not only once, but twice 
with one week wash out in between, the test-retest repeatability of exercise-induced effects 
could also be assessed. This part of the Protégé study is described in chapter 3. For the next 
two studies, PEANUTS Pilot and PEANUTS Study, it was the aim to evaluate a less strenuous 
exercise intervention with also less trained, but overall healthy men and women. The focus 
now switched to intestinal permeability towards a dietary protein from peanuts, Ara h 6. 
Chapter 4 focusses on the development of the method within the PEANUTS Pilot study to 
detect this peanut-derived protein. Several factors that could potentially hamper the 
detection of Ara h 6 in serum after peanut consumption were evaluated. In chapter 5, this 
knowledge was taken into practice with the PEANUTS Study in which the developed method 
was applied to compare the effect of the exercise intervention on the paracellular 
permeability to lactulose with the passage of the peanut-derived protein Ara h 6. In chapter 
6, the focus moved from in vivo human trials to in vitro mechanistic studies. A Caco-2 
intestinal epithelial cell model was developed to evaluate the potential role of the 
mitochondrial oxidative metabolism in intestinal integrity. This part was performed to gain 
more understanding in one of the potential mechanisms that could underlie the exercise-
induced increase in intestinal permeability. Last, chapter 7 discusses the main findings of this 
thesis, strength and weaknesses of the study designs, future perspectives and closes with 
some general conclusions. This general discussion is followed by a brief summary in English 
of the main issues addressed in this thesis.  
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Abstract 
Exercise is one of the external factors associated with impairment of intestinal integrity, 
possibly leading to increased permeability and altered absorption. Here, we aimed to 
examine to what extent endurance exercise in the glycogen-depleted state can affect 
intestinal permeability toward small molecules and protein-derived peptides in relation to 
markers of intestinal function. Eleven well-trained male volunteers (27±4 years) ingested 40 
g of casein protein and a lactulose/rhamnose (L/R) solution after an overnight fast in resting 
conditions (control) and after completing a dual – glycogen depletion and endurance – 
exercise protocol (first protocol execution). The entire procedure was repeated 1 week later 
(second protocol execution). Intestinal permeability was measured as L/R ratio in 5 h urine 
and 1 h plasma. Five hour urine excretion of betacasomorphin-7 (BCM7), postprandial 
plasma amino acid levels, plasma fatty acid binding protein 2 (FABP2), serum pre-
haptoglobin 2 (preHP2), plasma glucagon-like peptide 2 (GLP2), serum calprotectin, and 
dipeptidylpeptidase-4 (DPP4) activity were studied as markers for excretion, intestinal 
functioning and recovery, inflammation, and BCM7 breakdown activity, respectively. BCM7 
levels in urine were increased following the dual exercise protocol, in the first as well as the 
second protocol execution, whereas 1 h-plasma L/R ratio was increased only following the 
first exercise protocol execution. FABP2, preHP2, and GLP2 were not changed after exercise, 
whereas calprotectin increased. Plasma citrulline levels following casein ingestion (iAUC) did 
not increase after exercise, as opposed to resting conditions. Endurance exercise in the 
glycogen depleted state resulted in a clear increase of BCM7 accumulation in urine, 
independent of DPP4 activity and intestinal permeability. Therefore, strenuous exercise 
could have an effect on the amount of food-derived bioactive peptides crossing the 
epithelial barrier. The health consequence of increased passage needs more in depth 
studies.  
  
Chapter 2 
24 
 
Introduction 
The intestinal epithelium is the body’s largest interface between the external and internal 
environment, regulating fluxes of ions, water, nutrients, and other molecules while 
protecting the host against potentially harmful agents and invading microorganisms. The 
importance of a well-functioning intestinal barrier is generally supported. At the same time, 
far less is understood about the nature and consequences of what is generally referred to as 
“increased intestinal permeability” [1, 2]. However, a “leaky gut” concept as persistently 
used in popular media as an all-embracing cause of multiple diseases is an obvious 
oversimplification [1]. In fact, “leaks” in the intestinal barrier, either discretely localized or 
scattered along the full length of the intestines, can relate to many distinct processes, such 
as an impaired mucus layer, disrupted tight junctions, an attenuated immune defense, 
changes in intestinal cell functionality, etc. Several studies relate impairment in absorption 
functions of the intestinal barrier, either intentional or unintentional, to the development of 
certain disorders, but knowledge on the exact mechanisms is lacking. As a consequence, a 
demand for a more detailed understanding of intestinal functioning remains, including 
insight in those processes and factors involved in impairment or restoration of its barrier 
function. 
Particular forms of physical stress, including strenuous exercise, are known to change barrier 
function. Intestinal integrity can be assessed by its permeability to small compounds, such as 
the inert sugar lactulose and by circulating markers of intestinal damage, such as fatty acid 
binding protein 2 (FABP2) and prehaptoglobin 2 (preHP2) [3, 4]. Several studies, although 
inconclusive [5, 6], have shown increased intestinal permeability to small molecules after 
exercise [7-10]. The lack in consistent outcomes might reflect that the various exercise 
studies are difficult to compare, also because they differ in type and intensity of exercise as 
well as in the methodology to assess intestinal permeability.  
The prevalence of food-dependent exercise-induced anaphylaxis furthermore suggests that 
increased absorption of intact and immunologically active proteins, or their fragments, after 
strenuous exercise is likely [11]. Although it has been shown, to some extent, that specific 
protein and protein-derived peptides are detectable in blood and urine after oral ingestion 
in humans [11-14], limited studies have been performed on the effect of strenuous exercise 
on the passage of intact proteins and their fragments. This is of relevance for extrapolation 
to the general population, because some fragments can have specific bioactive activities or 
may induce adverse reactions of the immune system.  
In a recent study, we used a dual exercise protocol involving both a glycogen depletion 
interval exercise and prolonged endurance exercise, which resulted in a clear post-exercise 
inflammatory response in well-trained individuals [15]. In this study, this protocol was 
applied to study intestinal integrity and intestinal function (digestion and enterocyte 
metabolic mass). The casein protein bolus ingested in this study is a source of several 
bioactive peptides, which are known for their resistance to digestion [16]. One of the casein-
derived bioactive peptides that have been identified in vivo is betacasomorphin-7 (BCM7). 
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The aim of this study was to determine the effects of a controlled dual exercise protocol [15]  
on intestinal permeability to small molecules and excretion of protein-derived peptides in 
relation to markers of intestinal function.  
Material and Methods 
Subjects 
Shortly after the competition season had ended, twelve well-trained healthy male cyclists 
were recruited via posters at the university, local sport centres, and via social media. 
Subjects were included with at least 2 years of cycling experience, a training frequency of at 
least two times a week during high season and no known records of milk allergy, immune 
diseases or intestinal diseases. Exclusion criteria were smoking, using hard drugs, using 
NSAIDs on a chronic basis, using any medication for gastric or intestinal complaints or 
donating blood during the last 6 weeks before the start and during the study. Subjects were 
requested not to perform intense physical activity 3 days prior to the test days. They were 
also instructed not to consume dairy-containing food products 2 days prior to and during the 
test days, not to use alcohol 4 days prior to and during the test days, and not to use soft 
drugs 2 weeks prior to and during the test days. This study was approved by the medical 
ethical committee of Wageningen University (METC-WU (13/10); CCMO Number 
NL44947.081.13), and conducted in accordance with the Declaration of Helsinki (revised 
version, October 2008, Seoul). Each of the subjects gave their written informed consent. 
Baseline testing 
Baseline testing was performed in the week prior to the start of the experimental protocol 
and consisted of anthropometric measurements including DEXA scan and a maximal aerobic 
capacity test. The maximal aerobic capacity test was adapted from [17] and performed using 
an electronically braked cycle ergometer (Lode Excalibur, Groningen, The Netherlands). After 
a short warming-up, the subjects started cycling at 100 W. Every minute the power 
increased with 20 W. The subjects had to cycle until they were no longer able to maintain 
the workload (Wmax; pedal frequency falling from 90 to 100 rpm to <70 rpm). O2-
consumption and CO2-production were measured with an Oxycon Pro (Jaeger, Hoechberg, 
Germany) to define the maximal aerobic capacity, VO2max. 
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Figure 2.1. Schematic overview of experimental design.  
This scheme shows the different stages of the 3-day experimental protocol (first protocol execution). This 
complete experimental protocol was repeated after 1 week in exactly the same way (second protocol 
execution). 
Study design 
This study had a single arm intervention design, with measurements performed during three 
conditions: rest, exercise, and 24 h post exercise (see Figures 2.1 and 2.2). Each subject 
acted as their own control (resting condition). The experimental protocol started with 
assessing intestinal permeability during the resting condition. The subjects arrived at the 
university after being fasted overnight (since 2300 h). A venflon cannula was inserted in the 
antecubital vein and blood was sampled (baseline-rest, taken as t = 0 for calculations). A 
baseline urine sample was also collected. This was followed by the ingestion of a multi-inert-
sugar test solution (see intestinal permeability testing) and a protein bolus containing 40 g of 
casein protein (Kind gift of Dutch Protein & Services BV, Tiel, The Netherlands) dissolved in 
400 mL of tap water. Blood and urine was sampled (with t=15 being 15 min after ingestion of 
casein) during the next 5 h at regular intervals, after which lunch was offered. The 5 h 
duration of sampling was chosen to accommodate possible slow digestion kinetics of casein 
[18, 19]. The exercise condition consisted of a dual exercise protocol and started in the 
evening following the assessment of the resting control condition. The subjects returned to 
the university 2 h after their regular dinner at home and completed the first part of the dual 
exercise intervention. This first part aimed at achieving glycogen depletion and consisted of 
2-min blocks of cycling alternating between very high intensity (90% Wmax ≈ 90% VO2max), 
and moderate intensity (50% Wmax ≈ 55% VO2max) at a pedal frequency of 90–100 rpm 
[20, 21]. When they were no longer able to cycle at 90% Wmax, the intensity was reduced to 
80% Wmax (still alternating with 50% Wmax), and subsequently to 70% Wmax. When 
alternating 70% and 50% Wmax could not be maintained, this exercise protocol was 
stopped. The subjects then received a small high-fat snack (Two crackers with peanut butter: 
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164 kCal of which 53 energy percent (En%) fat and 26 En% carbohydrates; or two crackers 
with pate: 260 kCal of which 61 En% fat and 32 En% carbohydrates) to reduce hunger 
feelings at night. They were not allowed to eat anything else until returning to the university 
the next morning, where they received the same high-fat snack before continuing with the 
second part of the dual exercise intervention. This second part consisted of 90 min of cycling 
at a moderate intensity of 50% Wmax, which can be considered strenuous in combination 
with the prior glycogen depletion part. Directly after completing the second part of the dual 
exercise protocol, a venflon cannula was inserted in the antecubital vein and blood was 
sampled (baseline-exercise, taken as t=0 for calculations). A baseline urine sample was also 
collected. This was again followed by the ingestion of the multi-inert-sugar test solution and 
the casein protein solution. Blood and urine was sampled (with t=15 being 15 min after 
ingestion of the casein protein solution) for 5 h at regular intervals, after which lunch was 
offered. The next morning, the subjects came back to the university once more (24 h post 
exercise condition) to donate a single fasted blood sample. This complete single arm 
experimental protocol was repeated after 1 week to test for reproducibility in outcomes. In 
the following sections, these two executions of the experimental protocol are referred to as 
first and second protocol execution.  
Blood and urine sampling 
Venous blood was sampled during rest and exercise at baseline and at 15, 30, 60, 90, 120, 
and 300 min after casein protein intake. In the two cases that the venflon catheter could not 
be successfully placed, blood was sampled by venapunction at baseline and at 60, 120, and 
300 min after casein protein intake. One fasted blood sample was drawn by venapunction 24 
h post exercise. Blood for the analyses was sampled in tubes (Vacutainer; Becton Dickinson, 
Breda, The Netherlands) containing either EDTA or EDTA supplemented with protease 
inhibitor cocktail (Sigma Aldrich, Zwijndrecht, The Netherlands), which were directly 
centrifuged at 2000 g for 10 min at 4°C, aliquoted and stored at -80°C within 20 min after 
sampling until further analysis. Blood was also sampled in serum separator tubes; it was left 
to clot in the dark for at least 30 min at room temperature, after which the tubes were 
centrifuged at 2000 g for 10 min at room temperature to obtain serum, which was directly 
aliquoted and stored at -80°C until further analysis. Collected urine was supplemented with 
chlorhexidine to prevent bacterial growth. During both the resting and the exercise 
condition, one urine sample was collected at baseline and urine was collected and pooled 
over a 5 h period following intake of the multi-inert-sugar and casein bolus. The total sample 
volume was recorded and aliquots were stored at -20°C until further analysis.  
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Parameters of intestinal permeability 
To study intestinal permeability to inert, nondigestible sugar molecules, a multi-sugar test 
solution was used containing three sugar probes: 5 g of lactulose, 1 g of L-rhamnose, and 0.5 
g of D-xylose (BCM Specials, Nottingham, UK). These sugars were dissolved in 100 mL tap 
water and ingested at the start of the resting condition as well as the exercise condition. To 
analyse urinary levels of lactulose, L-rhamnose, and D-xylose, 250 μL urine was diluted 20 
times with 0.08 mmol/L AgNO3 to precipitate chloride, after which the supernatant was 
desalted by eluting it over a Dionex Onguard Ba and H column (Thermo Fisher Scientific BV, 
Breda, The Netherlands). This eluate was analysed by HPAEC (Dionex-HPLC ICS5000; Thermo 
Fisher Scientific) using pulsed electrochemical detection. Urinary sugar probe excretion was 
calculated by multiplying the concentration of each of the sugars probes with urine volume, 
after which the baseline excretion was subtracted. Recovery of the sugar probes was 
expressed as percentage of the orally ingested dose. Lactulose-to-L-rhamnose (L/R) ratios 
were calculated from the urinary excretion levels. An increased L/R ratio implies increased 
intestinal permeability. Levels of lactulose, L-rhamnose, and D-xylose were also measured in 
EDTA plasma. 125 μL EDTA plasma was transferred to Eppendorf tubes containing a 3000 Da 
cut-off filter (Amicon Ultra 0.5 mL 3 K; Millipore) to remove the plasma proteins. The filter 
tubes were centrifuged for 30 min at 11,000 g at 4°C, and clear plasma filtrate was inserted 
in the cooled sample processor (233 XL; Gilson, Middleton, WI). Sugars were subsequently 
analysed by LC-MS as described elsewhere [22]. Plasma L/R ratios were calculated from the 
1 h plasma concentrations corrected for the concentrations found at the respective baseline. 
Betacasomorphin-7 and dipeptidylpeptidase-4 
To measure intestinal passage of protein-derived peptides, a specific fragment of casein, 
betacasomorphin-7 (BCM7), was measured in baseline and 5 h urine samples, cleaned-up by 
centrifugation through a 30 kD cutoff filter (Amicon Ultra; Merck Millipore, Co. Cork, 
Ireland). Flat-bottom ELISA plates (MaxiSorp, Nunc, Roskilde, Denmark) were coated with 
100 μL 1.5 μg/mL BCM7-polylysine conjugate solution. The analysis was performed in 
duplicate with the competitive ELISA described elsewhere [23] in which the primary anti-
BCM7 polyclonal antibodies (Abnova, Taipei, Taiwan) were used in concentration of 3.4 
μg/mL. Dipeptidylpeptidase-4 (DPP4; EC 3.4.14.5) is the only enzyme able to breakdown 
BCM7 [24]. Therefore, serum activity of DPP4 in sample taken at baseline, as well as 60 and 
120 min after casein intake, were determined for its potential effect on urine BCM7 levels. 
The photometric method was used as described by Wasilewska et al. [25]. The calculations 
were made after adjusting the measurements with the blank; the enzyme activity was 
calculated as: 100 9 (E-C)/S (where E, C, and S stand for the absorbance of the test, control, 
and standard samples, respectively). One unit of the enzyme activity was defined as the 
amount of the enzyme liberating 1 μmol p-nitroanilide/min/L test serum at 37°C. 
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Intestinal damage and recovery markers 
FABP2 was measured as an acute marker of small intestinal injury in EDTA plasma (1:1) with 
an in-house developed ELISA, as described elsewhere [26]. Serum prehaptoglobin-2 
(preHP2), also known as zonulin, was measured as a marker of intestinal integrity in serum 
(1:20) with a commercial ELISA kit (Immundiagnostik AG, Bensheim, Germany), following the 
instructions of the manufacturer. This ELISA kit only detects the active, uncleaved, form of 
preHP2. Plasma glucagon-like peptide 2 (GLP2) [1–34] levels were measured because this 
compound is positively related to improvement of intestinal permeability [27]. GPL2 was 
measured in duplicate in EDTA plasma treated with protease inhibitor using a commercial 
ELISA kit (Phoenix pharmaceuticals, Karlsruhe, Germany) according to instructions of the 
manufacturer. Prior to testing, 200 μL of plasma was loaded onto a pretreated C18 SEP-
column (Phoenix Pharmaceuticals) to remove proteins, after which the eluent was freeze-
dried. The lyophilized samples were reconstituted in 125 μL assay buffer. 
Inflammatory marker 
Serum calprotectin is an antimicrobial protein considered to be an early parameter of 
systemic inflammation [28]. Calprotectin analyses were performed with the EliATM 
Calprotectin assay following manufacturer’s instructions (14-5610-01; Thermo Fisher 
Scientific, Etten-Leur, The Netherlands) by a specialized medical laboratory (SHL, Etten-Leur, 
The Netherlands). 
Amino acid and urea levels 
Plasma amino acids (AAs) were analysed with HPLC after precipitating plasma proteins in 50 
μL plasma with 200 μL 3% perchloric acid. Individual AAs were determined by UFLC 
(Shimadzu, ’s-Hertogenbosch, The Netherlands) using a precolumn derivatization with 
ophtaldialdehyde and fluorimetric detection [29]. Urea is a primary metabolite derived from 
dietary protein and was measured in serum (1:100) with a commercial assay (Abcam, 
Cambridge, UK). 
Statistics 
Repeated measures ANOVA with Tukey’s multiple comparison tests were used to assess 
changes in plasma GLP2, serum and plasma FABP2, serum preHP2 in response to exercise 
(exercise condition) and casein intake only (resting condition) (GraphPad Prism 6, GraphPad 
Software Inc., San Diego, CA). Ratio paired T-tests were used to assess changes in urinary 
and plasma sugars probes, L/R ratios, urinary BCM7 and serum calprotectin between resting 
and exercise condition (GraphPad Prism 6). When urinary BCM7 levels were too low to 
detect in the urine, a lower level of detection (1.0 ng/mL) was imputed to enable paired 
statistics. Exercise, protocol execution, and exercise x protocol execution were the fixed 
parameters of the mixed model with LSD estimated marginal means which was used to 
assess changes in AA levels and AA-level-derived incremental area under the curve (iAUC) in 
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response to exercise and casein intake (IBM SPSS Statistics 22, IBM Corporation, Armonk, 
NY). 
Results 
Subject characteristics 
Physical parameters of the 11 male volunteers are shown in Table 2.1. 
 
Table 2.1. Subject characteristics 
Age (years) 26.7 ± 3.5 
Height (m) 1.87 ± 6.5 
Weight (kg) 77.8 ± 9.4 
BMI (kg/m2) 22.2 ± 1.5 
Fat mass (% of total mass) 13.6 ± 6.1 
Wmax (W) 406.4 ± 25.4 
VO2max (mL/kg/min) 62.5 ± 6.0 
Data are shown as mean ± SD, n = 11.  
Exercise-induced intestinal damage 
To assess exercise-induced effects on intestinal permeability, urinary as well as plasma 
recovery levels of lactulose and L-rhamnose were determined and calculated as L/R ratios. 
Five hour urinary lactulose, L-rhamnose, and L/R ratios were not different after exercise 
compared with resting conditions (Figure 2.3). In contrast, plasma L/R ratio was increased 1 
h after exercise (P = 0.01), suggesting an increase in intestinal permeability, mainly explained 
by a decrease in plasma L-rhamnose (P = 0.002). However, this was only the case during the 
first session. During the second protocol execution, there was no change in plasma L-
rhamnose and L/R ratio, suggesting no change in intestinal permeability. Urinary and plasma 
levels of xylose were similar for all conditions. 
Urinary BCM7 levels 
Urinary levels of BCM7 were increased after ingestion a single bolus of casein protein during 
the exercise condition compared to the resting condition (P = 0.03 for both protocol 
executions) (Figure 2.4A), suggesting increased intestinal absorption. These effects were 
similar for the first and second protocol execution. Serum DPP4 activity was measured, as 
that can have an effect on circulating BCM7 levels. There was no effect of casein protein 
intake on DPP4 activity and therefore average activity (baseline, T = 60 and T = 120) for the 
resting condition compared to the exercise condition are shown. The levels of this peptidase 
were similar for each of the conditions (Figure 2.4B) and individual BCM7 and DPP4 activity 
levels were not correlated (R2 = 0.024, P = 0.38). The effect of exercise on small intestinal 
epithelial damage was determined by assessing levels of circulating FABP2. Figure 2.5A 
shows that plasma FABP2 levels were not increased directly after exercise compared to the 
resting condition, suggesting no intestinal epithelial damage had taken place. During both 
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protocol executions, however, FABP2 levels decreased significantly 1 h after casein intake, 
independent of exercise, and in both protocol executions those levels increased again to 
resting levels during the exercise condition and 24 h post exercise. In line with this finding, 
there was no change in serum preHP2 levels when comparing the resting condition with the 
exercise condition (Figure 2.5C). There was, however, a significant increase (First protocol 
execution P < 0.0001 and second protocol execution P = 0.008) in serum calprotectin levels 1 
h after completing the dual exercise protocol (Figure 2.5B) compared to resting condition 
baseline levels, indicating the presence of inflammation. During the second protocol 
execution, serum GLP2, a hormone that is involved in intestinal repair, was increased after 
the combination of exercise and casein compared to resting condition baseline values 
(Figure 2.5D). 
Plasma AA profiles 
A single bolus of 40 g casein protein was ingested during the resting condition as well as 
during the exercise condition. Data on all AAs are in Table 2.2. As an effect of exercise, 
serum urea levels increased compared to the levels in the resting condition (Figure 2.6), 
suggesting increased AA oxidation or breakdown under these circumstances. Absolute 
plasma taurine levels were constantly higher during the exercise condition compared to 
resting conditions (Figure 2.7H). The postprandial increase in total AA due to casein protein 
intake was diminished after exercise (iAUC; P = 0.014) (Figure 2.7A). This effect is mainly 
explained by a less pronounced increase in nonessential amino acids (nEAA) (iAUC; P < 
0.001) and partly by a smaller increase in plasma essential amino acids (EAAs) (iAUC; P = 
0.044) (Figure 2.7B and C). Within the group of nEAA, alanine had the largest contribution to 
the diminished increase in plasma levels (Figure 2.7G). A striking effect of exercise was found 
on the citrulline levels after casein intake (Figure 2.7D). During the exercise condition, the 
increase in citrulline was virtually absent (iAUC, P < 0.001), with a 10-fold smaller iAUC 
compared to resting during the first protocol execution (1216 μmol min/mL vs. 120 μmol 
min/mL) and an almost threefold lower iAUC compared to resting during the second 
protocol execution (1341 μmol min/mL vs. 488 μmol min/mL) (Table 2.2). Citrulline can be 
produced by the intestine from glutamine. The cumulative plasma levels of glutamine and 
glutamate (GLX), however, did not show a significantly lower postprandial iAUC after 
exercise (Figure 2.7E). Citrulline can undergo renal conversion into arginine (Figure 2.7F). As 
for citrulline, total plasma levels of arginine were lower during the exercise condition 
compared to the resting condition (Table 2.2). 
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Figure 2.6. Effect of exercise and casein intake on serum urea levels 
Data are shown as mean ± SEM. Serum levels during the first (black) and second (striped) protocol execution 
are compared between the resting condition (rest) and exercise condition in combination with 1h casein intake 
(Rest and Ex 1h Cas). The * symbol depicts P<0.05. 
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Figure 2.7. Effect of exercise on postprandial plasma amino acid levels 
Plasma levels of total AAs (A), EAAs (B), nEAAs (C), citrulline (D), glutamine+ glutamate (GLX; E), arginine (F), 
alanine (G), and taurine (H) following casein bolus intake are shown as mean ± SEM. Comparisons are made for 
the first (open circles) and second (closed squares) protocol execution between the resting condition (line) 
versus exercise condition (dashed line). N=10 for first protocol execution. Significant differences are depicted 
with * when different for both protocol executions and *1 when different for the first protocol execution only. 
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Discussion 
Passage of betacasomorphin-7 (BCM7)  
Despite an apparently small increase in sugar permeability after exercise as seen from the 
classical L/R sugar test, exercise clearly increased the excretion of the casein-derived 
peptide, BCM7, in 5 h urine. The urinary concentrations of this fragment were elevated after 
exercise during both protocol executions. These findings indicate that the intestinal passage 
of proteins and (or) their fragments- peptides is more prone to effects of exercise compared 
to the absorption of sugars, which may be due to different mechanisms being involved. The 
appearance of these peptides is probably not facilitated via the paracellular pathway, as the 
absence of changes in lactulose indicates unchanged paracellular transport. Decreased L-
rhamnose and unchanged D-xylose, respectively, indicate a decreased or unaltered, but not 
increased, noncarrier mediated transcellular transport. Finally, the increase in BCM7 cannot 
be directly explained by a difference in breakdown by dipeptidylpeptidase- 4 (DPP4), 
because there was a similar systemicDPP4 activity in both conditions. BCM7 is a bioactive 
peptide which can act as an opioid receptor agonist. BCM7 has also been implicated in 
several beneficial and adverse health effects, reviewed in detail by the European Food Safety 
Authority [30] and Haq et al. [31]. Almost all studies on the effects of BCM7, however, have 
been performed in vitro or with animal models. Evidence of health effects of BCM7 in 
humans is limited to epidemiological data. The EFSA therefore concluded that a causal 
relationship between BCM7 exposure and chronic disease risk could not be supported by the 
existing data. Our data provide an answer to one of the knowledge gaps presented by the 
EFSA [30] by showing that casein-derived peptides can indeed be transferred intact across 
the intestinal barrier. We have also attempted to measure levels of casein and casein-
derived peptides in the plasma with a casein and beta-casein sandwich ELISA as well as HPLC 
MS/MS techniques, but we were unable to obtain the required detection sensitivity and 
specificity. Endurance exercise in the glycogen depleted state resulted in increased levels of 
BCM7 in urine after casein consumption, but whether and how these levels could 
subsequently amplify either beneficial or adverse health effects, requires further 
investigation. 
 
Effects on intestinal integrity 
Our dual exercise protocol did not induce similar effects on aspects of intestinal integrity as 
was found in previous studies. For example, FABP2, an acute enterocyte damage marker, 
was not affected in this study, while van Wijck et al. [7] found a clear increase in plasma 
FABP2 levels during and directly after exercise. The cause for the initial decrease in FABP2 
levels following 1 h of casein intake in this study has recently been investigated. We figured 
out that cycling, the usual way of transportation, in a fasted condition to the test location 
already results in increased levels of FABP2 (unpublished data- chapter 5). This may explain 
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our results, as a baseline blood sample was drawn directly after arrival at the test location. 
The FABP2 level determined after 1 h rest likely reflects the “actual” individuals’ baseline 
level. No additional effect of the endurance exercise was found. This may be due to the 
lower cycling intensity of 50% Wmax used in our protocol compared to 70% Wmax in van 
Wijck et al. [7], as data were obtained with the same assay. It should be noted, however, 
that the exercise protocol used in this study can still be regarded as intensive, which is for 
example reflected by the release of calprotectin from skeletal muscle [28]. Another 
explanation could be that the intensive glycogen depletion exercise phase the evening 
before the endurance exercise phase may have had a preconditioning, and even protective 
effect, thereby influencing the effects of the endurance exercise phase the next day. 
Preconditioning effects are seen following antioxidant supplementation [32] or with 
preoperative clamping [33]. The latter activates repair mechanisms in the gut and results in 
reduced damage from ischemia during the surgery itself. In this study, it was chosen to 
handle the dual exercise protocol as a single intervention. It would have been also 
interesting to study the responses evoked by each of the two phases of exercise separately.  
Changes in AA profiles after casein intake 
The increase in total plasma AA levels after casein intake was much lower after exercise 
when compared to the resting condition. As only venous blood was sampled, AA levels may 
have been influenced by organ uptake and release. Lower levels of total AA levels in plasma 
could be due to a combination of decreased digestion and absorption in the intestine and 
more rapid clearance resulting from tissue uptake (e.g., liver and muscle) as source for 
gluconeogenesis and/or for protein synthesis [34]. Casein is able to promote postprandial 
protein deposition [19], which is beneficial in an exercise condition. Decreased gastric 
emptying due to the endurance exercise would also lower plasma AA levels. It has, however, 
been shown that gastric emptying during exercise at the applied intensity occurs at a rate 
similar [35, 36] or faster than during rest [37], depending on the meal. The lower plasma 
total AA levels after exercise were mainly explained by lower levels of nonessential amino 
acids (nEAA), in particular of alanine. This effect on nEAA levels was not observed in a 
previous study with resistance-type exercise, in which mainly the postprandial essential 
amino acid (EAA) levels were lowered, whereas postprandial nEAA levels were not affected 
[38]. A possible explanation for this finding could again lie in the protocol set-up aimed at 
glycogen depletion. Gluconeogenesis is an important process during fasting, especially in 
combination with glycogen depletion, in order to maintain blood glucose levels [39, 40]. The 
most important AA precursor for gluconeogenesis is alanine, which is also the AA of which 
systemic levels decrease most rapidly during fasting [41]. An exception to the decrease in 
circulating AAs was the higher plasma levels of taurine after exercise compared to those 
following resting. Taurine can be released upon muscle contraction [39, 42], which likely 
explains this finding.  
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Intestinal metabolic capacity 
Circulating citrulline is often used as a clinical measure of total intestinal metabolic mass 
[43]. The absence of an increase in circulating citrulline after ingestion of casein following 
the dual exercise protocol could reflect a reduced intestinal metabolic capacity. Two 
important AAs in citrulline metabolism are glutamine and arginine, as a precursor and 
product of citrulline, respectively. Depletion of glutamine, which is the main fuel for 
enterocytes, results in plasma citrulline depletion [44, 45]. Findings in mice suggest that 
during shortage of available glutamine, enterocytes possibly prioritize its utilization for 
energy over the production of citrulline [46]. Therefore, during periods of energy stress (i.e., 
fasting and exercise) the glutamine taken up by the intestine may not be converted into 
citrulline. Our results suggest that after strenuous exercise the intestine’s energy stores or 
metabolic capacity may be insufficient to convert available glutamine from a casein protein 
bolus into citrulline. This agrees with the parallel decrease in arginine. Metabolic flux studies, 
with stable isotopes could give more insight in the intestinal uptake and conversion of 
available glutamine.  
Conclusion 
In conclusion, we show that the presented dual exercise protocol, combining glycogen 
depletion and endurance exercise, induces a clear increase in the casein-derived BCM7 
peptide ending up in the urine, independent of paracellular and noncarrier-mediated 
intestinal permeability or DPP4 activity. This shows that strenuous exercise could have an 
effect on the amount of food-derived bioactive peptides crossing the epithelial barrier. The 
health consequences of increased passage of these peptides need more in depth studies to 
determine whether and what effects can occur at the levels found.  
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New Findings 
x What is the central question of this study? 
Exercise is known to induce stress-related physiological responses, such as changes in 
intestinal barrier function. Our aim was to determine the test–retest repeatability of these 
responses in well-trained individuals. 
x What is the main finding and its importance? 
Responses to strenuous exercise, as indicated by stress-related markers such as intestinal 
integrity markers and myokines, showed high test–retest variation. Even in well-trained 
young men an adapted response is seen after a single repetition after 1 week. This finding 
has implications for the design of studies aimed at evaluating physiological responses to 
exercise. 
Abstract 
Strenuous exercise induces different stress-related physiological changes, potentially 
including changes in intestinal barrier function. In the Protégé Study (ISRCTN14236739; 
www.isrctn.com), we determined the test–retest repeatability in responses to exercise in 
well-trained individuals. Eleven well-trained men (27 ± 4 years old) completed an exercise 
protocol that consisted of intensive cycling intervals, followed by an overnight fast and an 
additional 90 min cycling phase at 50% of maximal workload the next morning. The day 
before (rest), and immediately after the exercise protocol (exercise) a lactulose and 
rhamnose solution was ingested. Markers of energy metabolism, lactulose-to-rhamnose 
ratio, several cytokines and potential stress-related markers were measured at rest and 
during exercise. In addition, untargeted urine metabolite profiles were obtained. The 
complete procedure (Test) was repeated 1 week later (Retest) to assess repeatability. 
Metabolic effect parameters with regard to energy metabolism and urine metabolomics 
were similar for both the Test and Retest period, underlining comparable exercise load. 
Following exercise, intestinal permeability (1 h plasma lactulose-to-rhamnose ratio) and the 
serum interleukin-6, interleukin-10, fibroblast growth factor-21 and muscle creatine kinase 
concentrations were significantly increased compared with rest only during the first test and 
not when the test was repeated. Responses to strenuous exercise in well-trained young 
men, as indicated by intestinal markers and myokines, show adaptation in Test–Retest 
outcome. This might be attributable to a carry-over effect of the defence mechanisms 
triggered during the Test. This finding has implications for the design of studies aimed at 
evaluating physiological responses to exercise. 
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Introduction 
The importance of a properly functioning intestinal barrier, serving as a gatekeeper that 
allows the absorption of nutrients and provides a line of defence against a variety of micro-
organisms and harmful molecules, is generally supported. Nevertheless, our understanding 
of the nature, regulatory mechanisms involved and consequences of what is generally 
referred to as ‘increased intestinal permeability’ is far from complete [1, 2]. As a 
consequence, there is a demand for methodology to measure and understand intestinal 
functioning in more detail. Exercise-induced changes in gut barrier function have been 
studied in several experimental settings [3-8]. Some of these studies have found an increase 
in intestinal permeability following exercise, whereas others have not. The same holds true 
for other exercise-induced parameters, such as the novel fibroblast growth factor-21 
(FGF21). This factor has been shown to increase [9] or remain unchanged [10, 11] following 
acute exercise. The same ambiguity is found for the effect of exercise training on resting 
levels of FGF21 [10, 12]. Inconsistencies in finding significant outcomes for these parameters 
are at least partly attributable to large variations in study set-up, such as participant 
characteristics, type and number of exercise sessions, and exercise intensity. This makes it 
difficult to draw final conclusions on the effects of exercise. The differences in outcome 
suggest a requirement for more in-depth research on the relationship between subjects, 
stressors and repeated bouts of exercise. Exercise performance is known to be trainable [13, 
14], but it is not entirely clear whether metabolic stress or tissue damage responses, such as 
increased intestinal permeability, are reproducible with repeated bouts of exercise in well-
trained individuals who are used to strenuous exercise. 
Insight into the test–retest variation of stress responses that are elicited by exercise may not 
only help to explain inconsistencies observed between different study results, but is also 
relevant to optimize exercise strategies for athletes and individuals with gastrointestinal 
disorders. In the present study, we examined the test–retest repeatability of well-trained 
individuals by exposing them to a strenuous exercise protocol for two consecutive weeks 
and studying markers of metabolic and cellular stresses and some immunological 
parameters. Hence, we applied a strenuous exercise protocol that comprised cycling in 
glycogen-depleted conditions, which has previously been shown to result in a significant 
immune response in trained individuals [15]. 
Methods 
Ethical approval 
This study was approved by the medical ethical committee of Wageningen University (METC-
WU; ISRCTN14236739) and conducted in accordance with the Declaration of Helsinki 
(revised version, October 2008, Seoul). All subjects gave their written informed consent. 
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Subjects 
Twelve well-trained healthy male cyclists were recruited via posters at the university and 
local sport centres and via social media shortly after the end of the cycling competition 
season. Subjects were included if they had at least 2 years of competitive cycling experience, 
trained at least two times a week during the competition season and had no known records 
of milk allergy, immune diseases or intestinal diseases. Exclusion criteria were smoking, use 
of drugs such as heroin, cocaine, and ecstasy, use of non-steroidal anti-inflammatory drugs 
on a chronic basis, or use of any medication for gastric or intestinal complaints. None of the 
subjects donated blood during the last 6 weeks before the start of the study. Subjects had to 
fill out a training diary, which validated that they only performed low-intensity (50% maximal 
aerobic capacity) endurance training sessions during the study period, but no intense 
physical activity, such as competing in a race or performing a vigorous training session, for 3 
days prior to the test days and between the two testing periods. They were also instructed 
not to use alcohol for 4 days prior to and during the test days and not to use cannabis 
products, such as hashish and marijuana, for 2 weeks prior to and during the test days. None 
of the subjects used non-steroidal anti-inflammatory drugs for 2 days prior to and during 
both testing periods. Data on baseline characteristics and the training volume of each of the 
subjects are shown in Table 3.1.  
 
Table 3.1. Subject characteristics 
 
Pre-study assessment 
Pre-study testing was performed 1 week prior to the start of the experimental period and 
consisted of anthropometric measurements, including a dual-energy X-ray absorptiometry 
scan and a maximal aerobic capacity test. The maximal aerobic capacity test was performed 
using an electronically braked cycle ergometer (Lode Excalibur, Groningen, The 
Netherlands). After a short warm-up, the subjects started cycling at 100 W, and every 
minute a 20 W increase was applied. The subjects had to cycle until they were no longer able 
to maintain the workload (Wmax). Oxygen consumption and CO2 production were 
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measured with an Oxycon Pro (Jaeger, Hoechberg, Germany) to define the maximal aerobic 
capacity. 
Study design 
This intervention study consisted of a repeated single arm, before-and-after intervention 
design, with each subject acting as their own control. The complete experimental protocol 
(Test) consisted of three phases: (i) rest; (ii) exercise; and (iii) 24 h postexercise (Figure 3.1). 
The subjects arrived fasted on the first day (Rest conditions), and a blood sample was taken 
(time t = 0). They ingested a non-digestible multisugar test solution (see ‘Sugar intestinal 
permeability test’), shortly followed by a protein shake containing 40 g of casein protein 
(kind gift of Dutch Protein & Services BV, Tiel, The Netherlands) dissolved in 400 ml of tap 
water. Blood was sampled after 1 h, and subjects received lunch. The same testing was done 
after a dual exercise protocol described by Carol et al. [15]. In short, the subjects came back 
to the university in the evening of the first day, 2 h after having their dinner at home. They 
were asked to stick to their usual eating habits. They completed a glycogen depletion 
exercise consisting of 2 min blocks of cycling, alternating between 90 and 50% Wmax at a 
pedal frequency of 90–100 r.p.m. When the subjects were no longer able to cycle at 90% 
Wmax (<70 r.p.m), the intensity was reduced to 80% Wmax (still alternating with 50% 
Wmax) and, subsequently, 70% Wmax. When alternating 70 and 50% Wmax could not be 
maintained (<70 r.p.m), the exercise was stopped. The subjects then received one of two 
small high-fat snacks (snack 1, 164 kCal, with 53% energy as fat and 26% energy as 
carbohydrate, chosen by four participants; or snack 2, 260 kCal, with 61% energy as fat and 
32% energy as carbohydrate, chosen by eight participants) to reduce feelings of hunger at 
night. The next day, the subjects came in fasted and received the same high-fat snack as 
before, after which they had to cycle for 90 min at 50% Wmax. Directly after completing the 
second part of the exercise protocol, a blood sample (time t = 0) was taken. Next, the non-
digestible multisugar test solution was ingested, shortly followed by the protein shake. Blood 
was sampled after 1 h, and the subjects received lunch. Finally, subjects came back the next 
morning (24 h postexercise) to donate a single fasted blood sample before receiving 
breakfast. This 3 day experimental protocol was repeated 1 week later (Retest) to evaluate 
the test–retest variation in the metabolic and stress/damage responses provoked by the 
dual exercise protocol. From now on, these two intervention periods are referred to as Test 
and Retest. Subjects were not allowed to switch between the two types of high-fat snack 
between the Test and Retest. 
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Figure 3.1. Schematic overview of blood sampling and analyses 
This scheme shows the dual exercise protocol and blood sampling during rest, exercise and 24 h postexercise 
(Test). This complete experimental protocol was repeated in exactly the same way 1 week later (Retest). The 
blood analyses performed at the different sampling time points are listed. Abbreviations: BHB, β-
hydroxybutyrate; CKM, creatine kinase, muscle-specific; FFA, free fatty acids; FGF21, fibroblast growth factor 
21; and Wmax, maximal workload. 
 
Blood and urine sampling 
During both rest and exercise, blood was sampled from the antecubital vein before (at t = 0) 
and 1 h after the intake of the sugar test solution and the casein protein shake. At 24 h 
postexercise, only a fasted blood sample was drawn. Blood was sampled in tubes 
(Vacutainer; Becton Dickinson, Breda, The Netherlands) containing either EDTA or NaF, 
which were directly centrifuged at 2000g for 10 min at 4°C, aliquoted and stored at −80°C 
within 20 min after sampling until further analysis. Blood was also sampled in serum 
separator tubes. It was left to clot in the dark for at least 30 min at room temperature, after 
which the tubes were centrifuged at 2000g for 10 min at room temperature to obtain serum, 
which was directly aliquoted and stored at −80°C until further analysis. During both rest and 
exercise, urine samples were collected before the intake of the sugar test solution and the 
casein protein shake, and supplemented with chlorhexidine to prevent bacterial growth. 
Total sample volumes were recorded, and aliquots were stored at −20°C until further 
analysis.  
Untargeted urine metabolomics 
Untargeted urine metabolomics was performed on samples collected before the intake of 
the multisugar test solution and protein shake at rest and following exercise. Urine samples 
were diluted with acetonitrile (1:1 ratio) and centrifuged. Hydrophilic interaction liquid 
chromatography-high resolution mass spectrometry (HILIC-HRMS) experiments were 
performed on a QExactive system (Thermo Electron Corporation, Waltham, MA, USA) 
consisting of a Dionex 3000 UltiMate RS autosampler, Dionex 3000 UltiMate UHPLC pump 
and a QExactive mass detector. The system is controlled using Thermo Fisher Scientific 
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XcaliburTM version 2.2 SP1.48 software. High-resolution full MS detection was carried out 
using  heated electrospray ionization (HESI) in both the positive and negative ionization 
modes using a scan range from m/z 100–1000 with the resolution set at 17,500. Prior to 
analysis of the study samples, the HRMS system was successfully calibrated in the positive 
and negative ionization mode to obtain high mass accuracy. Liquid chromatography–mass 
spectrometry (LC-MS) profiling was performed using hydrophilic interaction liquid 
chromatography and a 13.5 min gradient from 10 mM ammonium formate in 95% 
acetonitrile to 10 mM ammonium formate in 50% acetonitrile. Peak detection and matching 
across LC-MS profiles were performed using the Rpackage XCMS version 1.30.3, based on 
the centWave method [16]. The resulting peak intensity table was processed using 
MetaboAnalyst 3.0 [17]. The number of features was reduced based on the interquartile 
range, and normalization to constant sum and auto scaling were applied. The resulting data 
table was used for principal component analysis. 
Muscle-related parameters 
Muscle-specific creatine kinase (CKM) released in response to exercise was measured using a 
commercial enzyme-linked immunosorbent assay (ELISA) kit (Ab185988; Abcam). Serum 
samples were diluted 200–8000 times with sample diluent in order to be able to interpolate 
the values from the standard curve. Concentrations of FGF21 in serum and plasma in 
response to exercise were measured with a commercial sandwich ELISA assay kit (DF2100; 
R&D Systems, Wiesbaden, Germany) according to instructions provided by the 
manufacturer. 
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Sugar intestinal permeability test 
The sugar solution for studying small intestinal permeability contained the following three 
inert, non-digestible sugar probes: 5 g of lactulose, 1 g of L-rhamnose and 0.5 g of D-xylose 
(BCM Specials, Nottingham, UK). These were dissolved in 100 ml of tap water. 
Concentrations of lactulose and L-rhamnose were measured to determine intestinal 
permeability [18, 19] in EDTA plasma sampled at t=0 and 1 h after the intake of the sugar 
test solution and the protein shake during rest and exercise. To remove plasma proteins, 
EDTA plasma (125 μl) was transferred to Eppendorf tubes containing a 3000 Da cut-off filter 
(Amicon Ultra 0.5 ml 3 K; Millipore, Cork, Ireland). The tubes were centrifuged for 30 min at 
11,000g and 4°C, and the clear plasma filtrate was inserted in the cooled sample processor 
(233 XL; Gilson, Middleton, WI, USA). Sugars were subsequently analysed by LC-MS as 
described elsewhere [20]. Plasma lactulose-to-rhamnose (L/R) ratios were calculated from 
the 1 h plasma concentrations and corrected for the concentrations found at t = 0. 
Immune markers 
Plasma concentrations of fractalkine (also known as CX3CL1), in response to exercise, were 
measured with a commercial sandwich ELISA assay kit (DCX310; R&D Systems) according to 
instructions provided by the manufacturer. Immune inflammation-related proteins 
[interleukin (IL)-1α, IL-1β, IL-1 receptor antagonist (RA), IL-2, IL-5, IL-6, IL-10, IL-12, IL-13, IL-
25, tumour necrosis factor-α (TNF-α), interferon-γ (IFN-γ), IFN-γ- induced protein 10 (IP-10), 
tumor necrosis factor superfamily member 14 (LIGHT), thymic stromal lymphopoietin (TSLP) 
and granulocyte-colony stimulating factor (G-CSF)] were determined in serum samples by an 
in-house developed multiplex technology (xMAP; Luminex), according to the Luminex 
instructions, as previously described [21]. Non-specific heterophilic binding of 
immunoglobulins was prevented with HeteroBlock (Omega Biologicals, Bozeman, MT, USA), 
and no cross-reactivity was observed. Acquisition was performed with a Bio-Rad FlexMAP3D 
in combination with xPONENT software version 4.1 (Luminex). Data analysis was performed 
with Bioplex Manager 6.1.1 (Bio-Rad, Veenendaal, The Netherlands). For each of the 
cytokines, a standard curve was taken along on each of the sample plates. When sample 
levels measured were lower than the lower limit of quantification (LLOQ), the values were 
set at 10% of this cut-off value to enable statistical analyses. 
Statistics 
Linear mixed model analysis with Bonferroni multiple comparison tests were used to assess 
changes in the concentrations of all compounds analysed, except plasma L/R ratios (IBM 
SPSS Statistics 22, IBM Corporation, Armonk, NY). Per protocol analyses were performed. 
Student’s paired t tests were used to assess changes in plasma L/R ratios between the rest 
and exercise conditions (IBM SPSS Statistics 22). Two-way ANOVA with Bonferroni post hoc 
testing was used to assess changes in RER and energy expenditure over time and between 
the rest and exercise conditions (GraphPad Prism 6, GraphPad Software Inc., San Diego, CA). 
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Student’s paired t test with a statistical significance of one-tailed P < 0.05 was used to test 
whether the effect size of CKM, FGF21 and L/R ratio was decreased during the Retest 
compared with the Test (GraphPad Prism 6). In addition, Spearman’s r correlation 
coefficients were calculated to determine the Test–Retest repeatability of the responses 
provoked by the dual exercise intervention. One subject was excluded because of non-
compliance with the instructions with regard to dietary guidelines. Some individuals were 
excluded from analysis when there were missing blood samples. Therefore, the number of 
subjects included in each of the analyses is 11, unless stated otherwise in the figure legends. 
Statistical significance was defined as a two-tailed P < 0.05. 
Results 
Markers of workload 
The impact of the exercise protocol on general metabolic markers, including glucose and 
lactate, was similar for both Test and Retest (see Figure 3.2). This is supported by the similar 
workload during the glycogen depletion phase and endurance cycling phase of the 
intervention protocol between Test and Retest (P > 0.05, data not shown). Plasma glucose 
concentrations were reduced directly after exercise, which was still the case 1 h later. For 
both Test and Retest, plasma lactate concentrations increased slightly, but significantly, 
following exercise. These levels returned to resting values within 1 h. Also, serum FFA and 
BHB concentrations showed similar patterns during rest and exercise, with a significant 
increase in concentrations following exercise. In contrast to BHB, serum FFA concentrations 
declined 1 h following exercise, although they were still slightly higher than the rest levels 
during the Test period (P = 0.03). Each of the metabolic markers showed a significant 
correlation between the Test and Retest outcomes (Table 3.2). There was no significant 
difference in RER between Test and Retest (Figure 3.3A). Indirect calorimetry indicated a 
decrease in the RER after exercise, implying that the metabolism had shifted towards lipid 
oxidation, rather than carbohydrate oxidation, after completing the dual exercise protocol 
(Figure 3.3B). There was also no significant difference between Test and Retest in energy 
expenditure (Figure 3.3C). Energy expenditure patterns showed a significant increase in 
energy expenditure following exercise (Figure 3.3D). Intake of casein induced a diet-induced 
thermogenic effect, as shown by a significant increase (P < 0.001) in the energy expenditure. 
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Figure 3.2. The effect of strenuous exercise on markers of energy metabolism 
Plasma glucose (A), plasma lactate (B), serum free fatty acids (FFA; C) and serum β-hydroxybutyrate (BHB; D) 
are shown as mean values + SEM. Comparisons are made with the rest values during the Test (black bars, n = 
10 for FFA and BHB) and Retest (grey hatched bars, n = 11) of the experimental protocol. Abbreviation: Cas, 
casein protein intake. כP < 0.05 and כככP < 0.001. 
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Table 3.2. Spearman correlation coefficients to Test – Retest correlation 
 
 
Figure 3.3. The effect of strenuous exercise and casein bolus intake on energy expenditure 
The respiratory exchange ratio (RER; A) and energy expenditure (C) are shown as the difference (Δ) between 
exercise and rest values ± SD (n = 8) at time t = 0 and 1, 2 and 3 h after intake of the sugar test solution and 
protein shake. To compare rest with exercise, RER values (B) and energy expenditure levels (D) of Test and 
Retest are taken together (n = 16). ככP < 0.01, כככP < 0.001 and ככככP < 0.0001. 
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Urine metabolomics 
Principal component analysis of the urine metabolic profiles revealed a clear separation 
between the urine metabolite profiles in the rest and exercise conditions (Figure 3.4; light 
and dark blue versus red and green). These shifts were similar for both Test and Retest, and 
there was no clear difference in metabolite profiles between Test and Retest. 
 
 
Figure 3.4. Principal component (PC) analysis plot of untargeted urine metabolomics 
The principal component analysis of urine metabolomics is shown, comparing the rest and exercise conditions 
(n = 11 for each condition) for both Test and Retest. 
Exercise-induced stress-related markers 
In contrast to the metabolic markers, parameters aimed at measuring exercise-induced 
stress or damage showed different patterns for Test and Retest. To assess exercise-induced 
effects on intestinal permeability, plasma concentrations of lactulose and L-rhamnose were 
determined and calculated as the L/R ratios. Figure 3.5 shows that during the Test period the 
plasma L/R ratio increased after exercise (P = 0.03). During the Retest period, such an 
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increase was not observed. Serum concentrations of CKM increased significantly straight 
after completion of the exercise protocol during the Test period, whereas during the Retest 
period it took 24 h for the concentrations to increase significantly from resting levels. The 
recently discovered metabolic marker FGF21 also showed a significant increase in serum 
concentrations 1 h after exercise, but during the Test period only. For each of the 
parameters of exercise-induced stress or damage, the effect size was found to be 
significantly larger during the Test period compared with the Retest period. In line with this 
finding, Test and Retest values were not significantly correlated with each other (Table 3.2). 
Exercise-induced cytokine response 
For most of the cytokines that were measured, no significant responses were observed 
(Table 3.3). Only four of the measured cytokines showed differences in their concentrations 
following exercise compared with rest. These cytokines are also shown in Figure 3.6. Serum 
IL-6 and IL-10 concentrations increased after exercise during the Test period only. Serum IP-
10 concentrations also only differed during the Test period, with a significant decrease after 
exercise. Fractalkine was the only exception and showed increased plasma concentrations 
following exercise compared with rest for both Test and Retest. In contrast to the exercise-
induced muscle-related markers, the cytokine responses during Test were significantly 
correlated with those during the Retest (Table 3.2). 
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Figure 3.5. The effect of strenuous exercise on intestinal permeability and muscle-stress markers 
Levels of serum muscle-specific creatine kinase (CKM; A), plasma lactulose-to-rhamnose (L/R) ratio (B) and 
serum fibroblast growth factor 21 (FGF21; C) are shown as mean values + SEM. Comparisons are made with the 
rest values during execution of the Test (black bars, n = 10) and Retest protocols (grey hatched bars, n = 11). 
The effect percentage is calculated for each individual. For serum CKM, the rest value is compared with the 
value postexercise (Post-ex); for the plasma L/R ratio and the serum FGF21 concentrations, the rest value is 
compared with the value 1 h after exercise. Abbreviation: Cas, casein 
protein intake. כP < 0.05 and ככP < 0.01. 
 
 
Chapter 3 
62 
 
Ta
bl
e 
3.
3.
 E
xe
rc
is
e-
in
du
ce
d 
cy
to
ki
ne
 re
sp
on
se
s d
ur
in
g 
tw
o 
pr
ot
oc
ol
 e
xe
cu
tio
ns
 
 
Adaptation of exercise-induced stress 
63 
 
 
Figure 3.6. The effect of strenuous exercise on cytokine response 
Plasma concentration of fractalkine (A), serum concentration of interleukin (IL)-6 (B), serum concentration of 
IL-10 (C) and serum IP-10 (D) are shown as mean values + SEM. Comparisons are made with the rest values 
during the Test (black bars, n = 11) and Retest (grey hatched bars, n = 11). Abbreviation: Cas, casein protein 
intake; IL, interleukin; IP-10, interferon gamma-induced protein 10. כP < 0.05, ככP < 0.01, כככP < 0.001, and 
ככככ P < 0.0001 
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Discussion 
The aim of the present study was to investigate test–retest repeatability of exercise-induced 
stress responses in well-trained subjects. Therefore, we measured a set of parameters for 
energy metabolism, markers of metabolic or cellular stress, and immunological factors. The 
finding that parameters for general energy metabolism (glucose, lactate, FFA and BHB) and 
energy expenditure did not differ between the Test and Retest period indicates that the 
subjects delivered a similar workload. Remarkably, most immune markers were found not to 
be affected by exercise in these well-trained individuals. The effects of the exercise protocol 
on systemic concentrations of CKM and FGF-21, the L/R ratio and concentration of some of 
the myokines, however, showed distinct patterns between the Test and Retest periods. The 
increase in concentrations of CKM, FGF-21, IL-6 and IL-10 and the increase in the L/R ratio 
were diminished or even absent during the Retest period compared with the Test period. 
These results suggest adaptation when the exercise protocol is repeated, even in these well-
trained individuals. The adaptation in intestinal permeability as measured with the L/R ratio 
suggests that the gut may be, at least to some extent, ‘trainable’, which could result in a 
reduction of the often reported gastrointestinal complaints by endurance athletes [22]. A 
clear distinction was observed between the urine metabolic profiles before and after 
exercise, but not between the Test and Retest. These results suggest that metabolites 
reflecting metabolic stress or tissue damage, although expected to be present, do not 
dominate the differences in metabolic profiles between rest and exercise. When two bouts 
of exercise are performed within a short time period (e.g. within 24 h), a carry-over effect in 
exercise-induced responses is often seen [23-25]. In the present study, however, the 
opposite was seen with the responses during the Retest compared with the Test, with the 
exception of IL-6. One week of washout, as applied in the present study, is quite long. There 
might be, however, a carry-over-like effect of the defence mechanisms activated during the 
test period that are still active during the Retest, thereby attenuating the stress response 
[26]. The considerable interindividual variation found in metabolic stress and tissue damage 
responses to the exercise protocol, especially during the Test period, may also, at least in 
part, be explained by this possible carry-over effect. 
The response levels of the myokine fractalkine were similar for the Test and Retest periods. 
This finding supports earlier results by Catoire & Kersten [11], who designated fractalkine as 
an ‘exercise factor’ which, according to their definition, should not adapt to training. 
Interleukin-10, in contrast, seems to be responsive to adaptation to repeated exercise and 
could be considered an adaptive exercise factor. In contrast, the possible carry-over effect of 
the Test protocol to the Retest protocol on the concentrations of IL-6 suggests that excluding 
intense physical activity for 3 days prior to a study trial may not be long enough to prevent 
carry-over effects from prior exercise. It is important to distinguish the effects that are 
attributable to adaptation from those resulting from carry-over for functional interpretation 
of outcomes of exercise protocols. 
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For some exercise-induced stress markers, such as the newly discovered marker FGF21, 
effects of exercise protocols were inconsistent in earlier studies, leading to disagreement on 
the relationship between exercise and FGF21 [9-12]. This can, at least in part, be attributable 
to the large differences between the exercise protocols, ranging from a single bout of 
exercise to several weeks of exercise intervention. However, response adaptation, as shown 
in the present study, could also form part of the basis of these inconsistent findings. It is 
interesting to speculate on the functional role of a stress response and subsequent 
adaptation by, for example, FGF21 induction. Strenuous exercise is associated with 
endoplasmic reticulum stress, which can result in skeletal muscle damage at excessive levels 
[27]. Secretion of FGF21 from skeletal muscle is induced in response to skeletal muscle 
endoplasmic reticulum stress leading to the activation of the integrated stress response, 
labelling FGF21 as a muscle-related stress marker rather than an exercise-induced myokine 
[27]. A transient elevation in endoplasmic reticulum stress is thought to be necessary for 
adaptive improvement through mitohormesis [27]. Repeated exercise could result in a 
higher resistance against skeletal muscle endoplasmic reticulum stress and, subsequently, 
also in an attenuated rescue signal of FGF21 [28]. 
Conclusions 
There seems to be an adaptation to exercise-induced stress or damage responses in well-
trained healthy young men. Perhaps this is attributable to a carry-over effect of the defence 
mechanisms triggered during the Test. This finding may explain, in part, inconsistent 
outcomes in the literature concerning several factors of exercise-induced stress. It also has 
implications for the design of protocols to assess exercise-induced responses. More research 
is required to determine the washout period needed to prevent adaptation and carry-over 
effects of prior exercises. When exercise interventions are not repeated within the study 
design, the duration of exercise restrictions prior to the start of the study may be an 
especially important factor to take into account. 
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Highlights 
• Peanut allergen can be detected with ELISA in serum after peanut consumption 
• Ara h 6-specific IgG and IgG4 antibodies inhibit detection of Ara h 6 in serum 
• This inhibition may be a broader phenomenon in studies on uptake of food allergens 
• This may explain variable serum levels of food allergen reported in literature 
Abstract 
Some studies have suggested that allergens may appear in the circulation after ingestion of 
allergenic food sources. The reported levels of allergen in serum, however, are low, and 
conclusions between studies differ. Here, we investigated factors that determine the 
detection of allergens in serum after consumption of peanuts. 
Ten healthy volunteers ingested 100 g of light-roasted peanuts. Serum samples were taken 
at regular intervals for six hours. A double monoclonal sandwich ELISA was used to analyse 
the presence and quantity of the major peanut allergen Ara h 6 in serum. 
In 4 out of 10 subjects, no Ara h 6 could be detected. Purified Ara h 6 that was digested in 
vitro was still reactive in the ELISA, rejecting the possibility that digestion leads to small 
peptides that could not be detected. Spiking of purified Ara h 6 in baseline serum showed 
that the pre-ingestion serum of these four subjects partially prevented Ara h 6 to react in the 
ELISA, with a reduction of reactivity of up to 3 orders of magnitude or more. Pre-ingestion 
serum of the other six subjects did not show such an effect. The reduction of reactivity of 
Ara h 6 coincided with high titres of IgG and IgG4, and removal of IgG from pre-ingestion 
serum abolished this effect completely, indicating that IgG and IgG4 inhibited the reactivity 
of Ara h6 in the ELISA. 
We conclude that some individuals have IgG and IgG4 against food allergens in their blood, 
which interferes with detection of such food allergens in serum. Because this effect does not 
occur for each individual, the possibility of such interference should be taken into 
consideration when interpreting immunochemical studies on the absorption of food 
allergens in serum. 
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Introduction 
Food allergies affect 2–3% of the population in Western countries, and peanut allergy is one 
of the most important food allergies because of 1) its persistent character, 2) the low 
amounts of peanut needed to trigger a reaction, and 3) peanut being a widely used food 
ingredient. Peanut conglutins Ara h 2 and Ara h 6 are the most potent allergens with regard 
to IgE-binding, skin prick test, and basophil test. IgE to these allergens has a high positive 
predictive value for diagnosing peanut allergy [1]. 
A characteristic of conglutins (2S–albumins) is their relative stability to digestion [2, 3]. 
Digestion of Ara h 2 and Ara h 6 by pepsin and trypsin has been investigated in the past, 
showing that these are only partially hydrolysed resulting in relatively large peptides of 
around 4 to 5 kDa and 10 kDa in size [4-6]. Such digestion-resistant peptides are exposed to 
the intestinal immune system as large protein fragments, potentially explaining the potent 
allergenicity of these allergens with regard to their capacity to sensitize. It has also been 
shown that digestion-resistant peptides can be taken up in the circulation, leading to 
systemic reactions in peanut allergic individuals. Several studies investigated the uptake of 
digestion-stable food allergens such as peanut [7, 8], egg [9] and wheat [10] in healthy 
individuals and animal models [11]. Ara h 2 and Ara h 6 have also been detected in breast 
milk of lactating women [12, 13] and mice [11]. Moreover, a case report revealed that 
transfusion of a blood product into a peanut allergic recipient led to an anaphylactic reaction 
explained by residual peanut in the blood of one of the donors who consumed peanut prior 
to donation [14]. Together these reports indicate that immunologically active fragments of 
peanut allergens can at least partially survive the gastro-intestinal tract, and may appear in 
the circulation to be transported to various compartments of the body. However, the 
reported values of peanut allergen taken up are low, and often close to the limit of 
detection. Also, large variability between studies and between individuals within studies is 
observed. Considering the digestion resistance of peanut conglutins and their fairly high 
abundance in peanut, one would expect more consistent and higher levels of such proteins 
in the circulation if these were indeed taken up by the intestine and transported into the 
blood.  
The aim of this work was to identify possible confounding factors for the detection of peanut 
allergens in serum after consumption of peanut. We selected Ara h 6 as representative of 
the potent peanut conglutin allergens. Ara h 6 is biochemically well characterised and 
appears as a homogenous protein, with limited isoforms. We recruited a group of 10 healthy 
individuals, sampled blood before and after digestion of peanuts and analysed their serum 
for the presence of Ara h 6 at various time points. Moreover, we performed spiking 
experiments to investigate if detected levels corresponded to expected levels, and which 
sera-derived factors could be responsible for interference. 
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Materials and Methods 
Healthy volunteers / subject 
Ten healthy subjects were recruited via social media and email database of the university's 
human nutrition division (Wageningen University, the Netherlands). Exclusion criteria were 
having (suspected) allergic symptoms after peanut ingestion, smoking, use of illicit drugs, 
NSAIDs on a chronic basis, or use of any medication for gastric or intestinal complaints. None 
of the subjects donated blood during the last six weeks before the start of the study. 
Subjects were also instructed not to eat peanut-containing foods nor use alcohol for 2 days 
prior to the test day. 
This study was approved by the medical ethical committee of Wageningen University (METC-
WU 15/34; NTR5655), and conducted in accordance with the Declaration of Helsinki (revised 
version, October 2008, Seoul). All subjects gave their written informed consent after the 
nature and possible consequences of the study had been fully explained. 
Each subject came to the university while having fasted overnight. Pre-ingestion blood was 
sampled after which they were asked to consume 100 g of light-roasted, unsalted peanuts 
obtained from a local supermarket (Albert Heijn; private label product) within 10 min blood 
was sampled in serum separator tubes 30, 60, 120, 240, and 360 min after finishing peanut 
consumption. Blood was left to clot in the dark for at least 20 min at room temperature, 
after which the tubes were centrifuged at 2000 g for 10 min at room temperature to obtain 
serum, which was directly aliquoted and stored at − 80 °C until further analysis. 
Peanut allergens 
Virginia peanuts obtained from the US were used to purify the various Ara h 6 preparations. 
Ara h 6 was purified essentially as described earlier [15] with one additional hydrophobic 
interaction chromatography step to remove traces of impurities. Post-translationally 
proteolytically processed Ara h 6 (hereafter named naturally processed Ara h 6) was purified 
from side fractions of the Ara h 6 purification (Koppelman S.J., unpublished data), which 
contained disulfide-linked molecules consisting of a 5 and 10 kDa chain with estimated purify 
of > 95%. Identity was proven by peptide mass finger printing (data not shown). Digestion-
resistant peptides from peanut conglutin (equimolar mix of the heavy isoform of Ara h 2, the 
light isoform of Ara h 2, and Ara h 6 were prepared by incubation of peanut conglutin with 
immobilized trypsin [6]. The fraction of Ara h 6 in the equimolar mix was 0.30 based on 
mass. The protein concentration of the digestion-resistant peptide mix (hereafter named 
digested mix of Ara h 2 and Ara h 6) is expressed in mg of Ara h 6 per mL to simplify 
comparison with other Ara h 6 preparations. 
ELISAs 
The Ara h 6 ELISA was from Indoor Biotechnologies (EL-AH 6, Cardiff, UK), utilizing two 
monoclonal antibodies. The instructions of the manufacturer were followed, except that in 
some cases the reference material was replaced by other Ara h 6 preparations. By using 
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extra dilutions of the standard, the lower limit of quantification was determined to be 0.024 
ng/mL (defined as the value corresponding to an absorbance of the blank + 10 SD), and the 
lower limit of detection to be 0.012 (defined as the value corresponding to an absorbance of 
the blank + 3 SD). Samples were tested in duplicate and experiments were performed at 
least twice. To compare reactivity of different Ara h 6 forms, EC50 values, defined as the 
concentration that leads to half-maximal absorbance, were calculated using the Graphpad 
Prism software, version 6.07. 
ELISAs for IgG and IgG4 were set-up as follows. Purified Ara h 6 was coated on ELISA plates 
(Nunc MaxiSorp® flat-bottom 96 well plate) at 3 μg/mL in PBS (pH 7.4; 136.89 mM NaCl, 1.47 
mM KH2PO4, 8.10 mM Na2HPO4, 2.68 mM KCl), 100 μL/well, overnight at 4 °C. Plates were 
washed once with PBS and then blocked with PBS containing 2% (W/W) bovine serum 
albumin (BSA, A6003, Sigma Aldrich, Zwijndrecht, NL), for 2 h at 37 °C under shaking 
conditions (300 rpm). After washing (3 times with PBS containing 0.05% Tween 20 (PBS-T)), 
diluted serum samples were pipetted in the wells in duplicate and were allowed to incubate 
for 2 h at 37 °C under shaking conditions (300 rpm). Wells were washed again (3 times with 
PBS-T) and a 1:500 dilution of horseradish peroxidase conjugated anti-human IgG (05–4220, 
Invitrogen, Breda, NL) or 1:500 dilution of anti-human IgG4 (ab99817, Abcam, Cambridge, 
UK) in PBS-T with 1% BSA was applied on the plates for 1.5 h at 37 °C under shaking 
conditions (300 rpm). Plates were further developed using 100 μL of TMB substrate (T0440, 
Sigma Aldrich). Colour development was stopped after 10 min by adding 100 μL of Stop 
reagent (S5814, Sigma Aldrich). Absorbances with oversaturated values were imputed at 4.1, 
representing the highest absorbance that can be measured with the ELISA plate reader 
(Synergy HT, BioTek, Winoski, VT, USA). 
Removal of IgG from serum 
Two times diluted pre-digestion serum (in PBS) was applied to a Protein G Sepharose 
Column (6518, BioVision, ITK Diagnostics bv, Uithoorn, NL), equilibrated with PBS. The flow-
through was collected and re-applied to the column four times. The final flow-through was 
collected as IgG-depleted serum. The column was washed and re-equilibrated according to 
the instructions of the manufacturer. 
Results and Discussion 
We applied an ELISA specific for Ara h 6 detection to study the presence of this allergen in 
serum of healthy individuals after consuming peanuts. Several hypotheses were tested to 
explain why the detected levels of Ara h 6 are low and variable. 
Hypotheses formulation 
An overview of some relevant subject characteristics of the study is provided in Table 4.1. 
Upon ingestion of peanuts, the serum samples at t = 60 min were tested for the presence 
and quantity of Ara h 6. In serum of four subjects (out of ten), Ara h 6 was undetectable, 
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while in the serum of the other six subjects low levels of Ara h 6 of 0.30 ± 0.16 ng/mL could 
be detected. The total amount of peanuts consumed was 100 g. Using a protein content of 
25% [16], and taking into account that the Ara h 6 content of (Virginia) peanuts is 
approximately 6% [17], the subjects ingested approximately 1.5 g of Ara h 6. If all had been 
taken up in the circulation, assuming no turnover of Ara h 6 and a blood volume of 5 L, this 
would have led to a concentration of 0.3 g/L, corresponding to 300,000 ng/mL. It is expected 
that the intestine functions as a barrier, preventing the uptake of larger undigested dietary 
components. The observation, however, that only 0.3 ng/mL is found, and not even in serum 
from all subjects, possibly illustrates a minor and variable part of ingested Ara h 6 being 
detected in serum. Three hypotheses were formulated to explain the low levels of uptake of 
Ara h 6 in serum. In these hypotheses we assume that there are additional factors beyond 
intestinal uptake function: 1) the ELISA is not reactive for hydrolysed or digested Ara h 6; 2) a 
matrix effect disturbs the analytical procedure; or 3) the time point chosen at first for serum 
collection of 60 min is not optimal. The sections below provide the results of testing the 
hypotheses.  
 
Table 4.1. Subject characteristics and Ara h 6 levels. 
 
Reactivity of hydrolysed or digested Ara h 6 in the Ara h 6 ELISA 
The epitopes that are recognised by the monoclonal antibodies utilised in the Ara h 6 ELISA 
are, to our knowledge, not mapped (personal communication with ELISA manufacturer, dd. 
March 2016). The ELISA manufacturer also does not provide information on the possible 
reactivity of processed or digested Ara h 6. It is therefore not known whether this ELISA can 
detect digested Ara h 6. A naturally hydrolysed (processed) form of Ara h 6 occurs naturally 
in peanut [18] and was recently purified and characterized biochemically (Koppelman S.J., 
unpublished data). This post-translationally proteolytically processed form is composed of an 
N-terminal part of about 5 kDa linked by disulphide bonds to the C-terminal part of about 10 
kDa, highly similar to the profile for digested Ara h 2 and Ara h 6 [6], and was used to 
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investigate the detection of digested Ara h 6 by the ELISA. The reactivity of the three 
different Ara h 6 preparations was tested in the Ara h 6 ELISA. Figure 4.1 shows the 
calibration curve of the purified (intact) Ara h 6, a curve of the naturally processed form of 
Ara h 6, and a curve of a mix of Ara h 2 and Ara h 6 treated with trypsin (normalised for Ara h 
6 concentration). Intact and naturally processed Ara h 6 show a comparable reactivity 
illustrated by EC50 values (concentration that leads to half-maximal absorbance) of 2.6 and 
3.0 ng/mL, respectively. To mimic digestion under more physiological conditions, a mix of 
Ara h 2 and Ara h 6 was treated with trypsin, leading to a protein profile for Ara h 6 
consisting of a 5 kDa and 10 kDa fragment held together by disulphide bridges as described 
above [6]. These digestion-resistant peptides were also tested in the Ara h 6 ELISA, and show 
a curve overlapping with that of naturally processed Ara h 6 (EC50 is 2.8 ng/mL). Together, 
this strongly suggests that Ara h 6 digested in vivo is still reactive in the Ara h 6 ELISA, 
although perhaps at a slightly lower level. It is therefore unlikely that digestion of Ara h 6 
prevents the detection by ELISA. The processed form of Ara h 6 purified from peanut was 
used as standard for the following ELISA experiments. The dynamic range of the calibration 
curve is 3 orders of magnitude, which allows the detection of large differences in reactivity 
of samples. 
 
Figure 4.1. Reactivity of Ara h 6 and hydrolysed forms of Ara h 6 in the Ara h 6 ELISA 
Open triangles (∆): Purified native (intact) Ara h 6; Closed circles (●): naturally processed Ara h 6 as purified 
from peanuts; Closed squares (■): mix of Ara h 2 and Ara h 6 treated with trypsin (Ara h 6 concentration in the 
mix was calculated and used on X-axis (as described in Methods) to enable comparison with other Ara h 6 
forms). 
 
Matrix effects of serum 
A serum sample was obtained from all subjects before eating peanuts. This pre-ingestion 
serum was spiked with various concentrations of naturally processed Ara h 6 to investigate 
any possible matrix effect. Figure 4.2 shows that in the majority of sera Ara h 6 could be 
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detected comparable to Ara h 6 in buffer. However, a marked inhibition of reactivity is 
observed in sera from four subjects. For subject no. 10, this inhibition is pronounced for low 
concentrations of Ara h 6, while detection was good for higher concentrations. For subjects 
no. 1, 8, and 9, the inhibition was much stronger, and for subject no. 9 the detection of even 
the highest concentration of Ara h 6 (12.5 ng/mL) was still very low. Taking into account the 
LOD of the ELISA, i.e. 0.012 ng/mL, this inhibitory effect is at least 3 orders of magnitude. 
We hypothesized that competing antibodies present in serum may cause the observed 
inhibitory effect. Immunoglobulin (Ig) toward dietary proteins is common and IgG may 
increase as a result of frequent ingestion of immune-reactive dietary proteins [19, 20]. A 
strong increase in IgG antibodies against food proteins such as peanut and egg is seen in 
immunotherapy studies. Oral immunotherapy with allergic subjects that normally avoid the 
offending food often results in an increase of serum IgG and functional blocking activity is 
demonstrated in basophil histamine release assays [21-24]. However, our subjects do not 
avoid but are regularly exposed to peanut (Table 4.1), and it is possible that they have IgG to 
peanut in their circulation. 
 
Figure 4.2. Reactivity of naturally processed Ara h 6 when mixed into pre-ingestion serum for the study 
subjects 
Calibration curve (closed circles: ●) is shown for the full dilution range. For spiking the baseline sera 0.4 ng/mL, 
1.6 ng/mL, 6.3 ng/mL, and 12.5 ng/mL of naturally processed Ara h 6 was used. Subject no. 1: ◊ ; subject no. 2: 
▼ ; subject no. 3: ▲ ; subject no. 4: ■ ; subject no. 5:  ; subject no. 6: ♦; subject no. 7:  ; subject no. 8: ∆ ; 
subject no. 9: □ ; subject no. 10:  . 
 
We have tested the pre-ingestion sera of the subjects in a direct ELISA for Ara h 6-specific 
IgG (Figure 4.3A) and Ara h 6-specific IgG4 (Figure 4.3B). The sera that did not show 
inhibitory effects in the Ara h 6 ELISA had low or absent IgG reactivity. In contrast, the sera 
from subject no. 1, 8, and 9 had considerable IgG reactivity for Ara h 6. The IgG titres 
coincided with the inhibitory potency. Interestingly, this picture is even more pronounced 
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for antibodies of the IgG4 subclass directed to Ara h 6 (Figure 4.3B). Serum from subject no. 
8 and 9 could be diluted over 1000 fold before losing reactivity. The sera that did not show 
an inhibitory effect in the Ara h 6 ELISA did not show clear IgG4 reactivity. Further evidence 
that IgG/IgG4 mediate the inhibitory effect is obtained when IgG was removed from serum 
using Protein G Sepharose. Figure 4.3C shows that IgG and IgG4 was removed efficiently 
(using the sera with highest titres; i.e. from subjects no. 8 and no. 9) and this resulted in 
almost complete abolishment of the inhibitory effect on Ara h 6 detection (Figure 4.3D). 
While in untreated serum from subject no. 8 and no. 9 a serum-dilution dependent effect on 
detection is observed, the IgG-depleted sera allowed detection and quantification of the Ara 
h 6 spikes well ( > 80% at a serum dilution of 4-fold; Figure 4.3D). 
A large inhibitory capacity of the serum coincided with a high titre of Ara h 6-specific IgG and 
IgG4. High IgG and IgG4 levels are seen especially in subjects with frequent habitual peanut 
ingestion, suggesting a possible association. For both characteristics of the sera the order of 
the effect was: subject no.9 > no.8 > no.1 > no.10. Moreover, the sera from subjects that 
showed no inhibitory effect also had low or non-detectable Ara h 6-specific IgG or IgG4 
titres. Thus, we conclude that for part of the subjects there is an inhibitory effect mediated 
by IgG and/or IgG4 against Ara h 6 that interferes with and skews the quantification of Ara h 
6 by ELISA. Earlier studies reported interaction of food proteins with immunoglobulins, in 
particular observed in patients with Coeliac disease [25, 26]. However, a potential inhibiting 
effect of such interaction on the detection of food allergens by immunochemical methods 
has not been considered so far. 
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Figure 4.3. IgG and IgG4 specific for naturally processed Ara h 6 in serum of study subjects inhibits reactivity 
in the Ara h 6 ELISA 
IgG and IgG4 ELISAs were performed to compare the Ara h 6-specific IgG and IgG4 titers of the sera from the 
study subjects. Markers are the same as in Figure 4.2. Panel A: Ara h 6-IgG titers of all subjects. Panel B: Ara h 
6-sepecific IgG4 titers for all subjects. Panel C: Ara h 6-specific IgG and IgG4 in serum from subjects no. 8 (black 
bar) and 9 (Striped bar) (subjects with highest inhibitory potency) before and after cleanup with Protein G 
Sepharose. Panel D: Detection of different levels of naturally processed Ara h 6 in serum from subject no. 8 and 
9 (subjects with lowest detection of naturally processed Ara h 6 spike) before and after cleanup with Protein G 
Sepharose. Solid line: befoe cleanup; dotted line: after cleanup. 
Time course of appearance of Ara h 6 in serum  
Due to the inhibitory effects of serum of subject no. 1, 8, 9, and 10 it was not possible to 
assess the amount of Ara h 6 that enters the circulation of these subjects and consequently 
non-detectable levels were reported in Table 4.1. Because the inhibitory effect is dependent 
on the Ara h 6 concentration (Figure 4.2) and because the optimal time point for 
determining the presence of Ara h 6 in serum is not yet known, we have evaluated the time 
course of appearance of Ara h 6 in serum for all 10 subjects from 30 min up to six hours, 
speculating that at some point in time the Ara h 6 would be high enough to overcome the 
inhibitory effect. Figure 4.4 shows that only for the subjects whose serum did not inhibit the 
Ara h 6 ELISA, Ara h 6 could be detected at any time point.  
Two key observations can be made from Figure 4.4. First, the detected levels of Ara h 6 
seem to be fairly low. Considering the dose of Ara h 6 ingested with 100 g of peanuts (appr. 
1.5 g), an average peak level of 0.34 ng/mL (± 0.20 ng/mL) after 60 min reflects only about 
0.0001% of the intake at that moment in time. This low peak level in serum could be due to 
low uptake or to rapid clearance, or a combination of both. It is consistent with the view that 
the intestine functions as a barrier against the uptake of oligopeptides [27]. 
Second, the time point where the maximal concentration of Ara h 6 is found differs per 
subject. Because maximum levels are detected in serum after 120 min in most subjects this 
seems a suitable sampling time point for uptake detection, although a time course should be 
made for full quantification. Because all subjects have lower than peak levels after 4 h, a 
period up to 4–6 h after ingestion presents a good time-frame to capture the progress of 
allergen appearance in serum. This is in line with other reports on the appearance of food 
allergens in circulation upon ingestion [7, 8, 26]. 
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Figure 4.4. Naturally processed Ara h 6 detection in serum of study subjects after peanut ingestion 
Ara h 6 ELISAs were performed to analyze the level of naturally processed Ara h 6 over time following 100 g of 
peanut intake. The values are shown as the average of two independent ELISAs. Markers are the same as in 
Figure 4.2. The AUC over time is on average 74.2 ± 42.1 ng·min/mL. 
Implications for future research 
Although literature describes some variation in peak levels of food allergens in the 
circulation after ingestion of allergen-containing foods, the levels are most often in the 
ng/mL range. As we demonstrate here, such low levels may be undetectable by 
immunochemical techniques in cases where the subjects have IgG/IgG4 against the relevant 
protein of interest. We utilise a sandwich ELISA, a common technique to detect and quantify 
allergens in complex matrices. A sandwich ELISA requires binding of at least two antibodies 
to two different epitopes of the allergen. Therefore, binding of an allergen to endogenous 
IgG/IgG4 may prevent reactivity in sandwich ELISA due to steric hindrance or occupation of 
amino acid sequences at or in close proximity to the antibody epitopes. ELISA formats that 
require only one antibody-analyte interaction (e.g. inhibition ELISA, direct ELISA, RAST 
inhibition [28]), may mathematically have a lower change for inhibition. The sensitivity of 
such formats is, however, not as good as that of sandwich ELISA, and possibly not sufficient 
to detect and quantify allergens in the ng/mL range. A very sensitive approach is the 
basophil histamine release assay. Dirks et al. [7] studied peanut allergen uptake using the 
basophil histamine release assay. While this was not designed as a quantitative assay, a 
dose-response effect was seen, and the time of peak presence of peanut protein was 
between 15 min and 2 h. Using the sensitivity of the assay (determined to be 5 pg/mL) the 
estimated concentration of peanut protein was in the higher pg/mL range, which is 
comparable to our observations. The basophil histamine release assay depends on allergen-
antibody interaction, so the presence of IgG/IgG4 in the serum of the subjects could disturb 
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this assay as well. Because samples of 10 subjects were pooled in this study, it is not clear if 
individual inhibitory effects could have occurred. 
Assays independent of analyte-antibody interaction may provide a way to circumvent such 
inhibitory effect. Mass spectrometry has been applied to detect cow's milk proteins [29] and 
peanut protein [13] in human breast milk, however the applied technique (i.e. peptide mass 
fingerprinting) is not quantitative. Truly quantitative mass spectrometry assays have been 
developed for peanut allergens, however these have not yet been applied for quantification 
of low concentrations of peanut allergens in serum or breast milk [30]. 
When comparing the concentration ranges reported for food allergens in serum with those 
of food allergens in breast milk, it seems that the concentrations in breast milk are higher. It 
can be hypothesized that peanut protein is transported via the circulation at low 
concentrations and is potentially circulated through the lymphatic system and excreted by 
the mammary gland, building up higher concentrations in breast milk. The role of IgG/IgG4 in 
this process is unknown. Bernard et al. [11] showed in a mouse model that Ara h 6, once in 
breast milk, could also interact with IgG. Whether this is also the case in humans needs to be 
further investigated. Also, the mechanism of the binding of IgG/IgG4 in relation to the 
transportation and clearance of food allergens in the circulation needs to be further 
investigated in order to better understand the relevance of intact food allergens (or large 
immunoreactive peptides of these allergens) circulating in serum after consumption. 
Conclusions 
We conclude that the presence of Ara h 6-specific IgG and IgG4 antibodies is a determining 
factor in the detection of Ara h 6 in serum. These antibodies, which are found in the blood 
circulation of healthy individuals and may be induced by consumption of peanut, interfere 
with the detection and quantification of Ara h 6 in serum. This may be a broader 
phenomenon in studies on the uptake of food allergens in circulation, and may explain why 
variable levels of food allergen in serum have been reported in literature. 
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Abstract 
Controlled studies on the effect of exercise on intestinal uptake of protein are scarce and 
underlying mechanisms largely unclear. We studied the uptake of the major allergen Ara h 6 
following peanut consumption in an exercise model and compared this with changes in 
markers of intestinal permeability and integrity. Ten overnight fasted healthy non-allergic 
men (n=4) and women (n=6) (23±4yrs) ingested 100 grams of peanuts together with a 
lactulose/rhamnose (L/R) solution, followed by rest or by 60 minutes cycling at 70% of their 
maximal workload. Significantly higher, though variable, levels of Ara h 6 in serum were 
found during exercise compared to rest (Peak P = 0.03; AUC P = 0.006), with individual fold 
changes ranging from no increase to an increase of over 150-fold in the uptake of Ara h 6. 
Similarly, uptake of lactulose (2-18 fold change, P = 0.0009) and L/R ratios (0.4-7.9 fold 
change, P = 0.04) were significantly increased which indicates an increase in intestinal 
permeability. Intestinal permeability and uptake of Ara h 6 were strongly correlated (r = 
0.77, P <0.0001 for lactulose and Ara h 6). Endurance exercise after consumption may lead 
to increased paracellular intestinal uptake of food proteins. 
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Introduction 
The food and Agriculture Organization of the United Nations predicted that the demand for 
animal-sourced foods will almost double between 2000 and 2030 due to the fast growth of 
the global population and changes in consumption patterns with an increase in urbanization 
in several parts of the world [1]. In order to close the gap between demand and supply, 
many research initiatives have been taken to study sustainable protein sources for food and 
feed [2-4]. In this quest, there is a strong focus on novel proteins derived from various 
sources such as plants, algae, food waste, and insects. Next to the technical criteria, 
questions that arise from the field of novel proteins are directed at their potential effects on 
human health, with respect to their digestibility and absorption [4], and their potency to 
activate the immune system [5]. The intestine is of major importance for the proper 
digestion and absorption of these novel proteins, but it also forms a protective barrier. 
Changes in intestinal barrier function (e.g. increased permeability) under different 
physiological conditions may result in increased absorption of large molecules including 
protein fragments [6-8], which could potentially induce an immune response. Mounting 
evidence indicates that increased intestinal permeability to antigens plays a key role in 
various inflammatory and autoimmune disorders, underlining the necessity to gain more 
insight into factors affecting intestinal barrier function [9]. 
The possibility that the intestine becomes permeable to certain macromolecules, 
presumably in a variable manner, has been acknowledged for some decades [8,10]. 
However, only very few studies in humans have investigated the uptake of intact dietary 
peptides and proteins in a controlled experimental setting [11]. 
An increased intestinal permeability to immune-reactive proteins or their fragments as a 
result of intensive exercise has also been postulated as a possible mechanism underlying 
food-dependent exercise-induced anaphylaxis [12,13].  
The aim of the present study was to substantiate the increase in intestinal permeability for 
dietary proteins upon exercise by determining the effects of a controlled exercise protocol 
on the uptake kinetics and levels of the peanut allergen Ara h 6 following peanut 
consumption and to relate this to markers of intestinal permeability and integrity. Ara h 6 
was chosen, because, together with Ara h 2, it is the major peanut allergen. Furthermore, 
Ara h 6 was shown to be resistant to digestion, which increases the possibility of detecting 
this specific protein in the circulation [14]. 
Subjects and methods 
Ethical approval 
This study was approved by the medical ethical committee of Wageningen University (METC-
WU 16/11; date of approval: 10 May 2016; Netherlands trial register: NTR5854, PEANUTS 
Study), and conducted in accordance with the Declaration of Helsinki. All subjects gave their 
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written informed consent after the set-up, objectives and possible consequences of the 
study had been fully explained. 
Subjects 
Ten healthy non-atopic subjects, based on exercise-induced effects on intestinal 
permeability, were recruited via social media and the email database of the university’s 
Division of Human Nutrition (Wageningen University and Research, NL). Exclusion criteria 
were exercise for > three hours per week, smoking, use of drugs, use of nonsteroidal anti-
inflammatory drugs (NSAIDs) on a chronic basis, or the use of any medication for gastric or 
intestinal complaints. Subjects did not perform intense physical activity three days prior to 
the test days. Subjects also did not eat peanut-containing foods one day nor used alcohol 
two days prior to the test days. Characteristics of the 10 subjects included in this study are 
shown in Table 5.1. 
 
Table 5.1. Subject characteristics 
I
D M/F 
Age 
(years) 
BMI 
(kg/m2) 
Wmax 
(watt) 
Consumption of products 
with high peanut content1 
Consumption of products 
with low peanut content2 
1 F 22 24.9 240 1x per week <1x per month 
2 F 21 22.7 200 <1x per month 1-3x per month 
3 F 22 25.6 320 1-3x per month 1-3x per month 
4 F 22 25.2 280 (Almost) daily 1-3x per month 
5 M 20 24.8 320 1x per week 1-3x per month 
6 M 21 24.7 360 1x per week 1x per week 
7 M 26 22.7 300 1-3x per month <1x per month 
8 M 32 23.5 300 1x per week <1x per month 
9 F 22 22.8 260 (Almost) daily <1x per month 
10 F 23 23.6 200 (Almost) daily 1-3x per month 
1 Examples: peanuts/ peanut butter/ peanut sauce 2 Examples: candy bars/ cookies/ muesli (bars) Wmax 
= Maximal cycling workload M/F = Male/Female BMI = Body Mass Index 
Pre-study assessment 
Pre-screening was performed prior to subject inclusion to prevent inclusion of subjects in 
whose serum no Ara h 6 would be reliably detected after peanut intake due to inhibiting 
effects of the serum matrix; e.g. because of the presence of Ara h 6-specific IgG and 
particularly IgG4 in the serum, which was found to be common in our study population [14]. 
This was tested with an in-house developed enzyme-linked immunosorbent assay (ELISA) 
[14]. Fasted blood samples were tested by spiking 3.1 ng/mL Ara h 6 in 1:1 diluted serum 
samples. Subjects with a spike recovery <50% were excluded from participation. 
A maximal aerobic capacity test (Wmax) was performed using an electronically braked cycle 
ergometer (Lode Excalibur, Groningen, NL). After a short warm-up, the subjects started 
cycling at 100W. Every minute the power increased with 20W until they were no longer able 
to maintain the workload (Wmax; Pedal frequency falling from 90-100 rotations per minute 
to less than 70). 
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Study design 
Each subject was tested once in rest and once during and following exercise. Test sessions at 
the university always started after an overnight fast. Pre-ingestion blood was sampled, after 
which 100 grams of mildly-roasted, unsalted peanuts, obtained from a local supermarket 
(Albert Heijn; private label product) were consumed within 10 minutes. This was directly 
followed by the intake of a solution of two inert, non-digestible, test sugars, containing one 
gram of L-rhamnose (Carbosynth, Compton, Berkshire, UK) and 0.5 grams of lactulose 
(Carbosynth) dissolved in 100 mL tap water. Participants were seated comfortably (rest). 
Blood was sampled in ethylenediaminetetraacetic acid (EDTA) plasma tubes (Vacutainer, 
Becton Dickinson, Breda, NL) as well as serum separator tubes (Vacutainer) at an interval of 
30, 60, 120, 240, and 360 minutes after their peanut consumption. EDTA blood tubes were 
directly centrifuged at 2000× g for 10 minutes at 4°C, after which plasma was aliquoted and 
stored at -80°C. Serum separator tubes were left to clot for at least 20 minutes at room 
temperature, after which the tubes were centrifuged at 2000× g for 10 minutes at room 
temperature to obtain serum, which was directly aliquoted and also stored at -80°C until 
further analysis. Analysis of Ara h 6 was performed in blood samples collected at t= 0, 30, 60, 
90, 120, and 240 min. Analysis of fatty acid binding protein-2 (FABP2) was performed in 
blood samples collected at t= 0, 30, and 60 min. Analysis of lactulose and rhamnose was 
performed in blood samples collected at t= 0 and 60 min. One week later, the same 
procedure was followed, yet this time the intake of the peanuts and the dual sugar solution 
was followed by endurance exercise. The endurance exercise involved individuals cycling for 
60 minutes at 70% of their Wmax, followed by rest for the remaining three hours. Again, 
blood was sampled in EDTA plasma tubes as well as serum separator tubes 30, 60, 90 120, 
and 240 minutes after finishing their peanut consumption. See Figure 5.1 for a schematic 
overview of the intervention and blood sampling. 
 
 
Figure 5.1. Schematic overview of study set up 
This scheme shows the blood sampling during Rest and Exercise. Black box depicts the intervention: 60 minutes 
of rest or 60 min of cycling at 70% of the individual’s maximal cycling workload (Wmax). The analyses 
performed with blood sampled at the different time points are listed. FABP2= fatty acid binding protein 
Peanut allergen Ara h 6 detection in serum 
Serum levels of Ara h 6 were determined with an Ara h 6 ELISA from Indoor Biotechnologies 
(EL-AH6, Cardiff, UK). The instructions of the manufacturer were followed, except for the 
reference material, which was replaced by naturally processed Ara h 6, as it occurs next to 
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its native intact form in peanuts [14]). This form of Ara h 6 supposedly better represents Ara 
h 6 after gastrointestinal digestion [15]. This naturally processed Ara h 6 has been 
thoroughly tested previously and has shown good reactivity in the assay [14]. The lower level 
of quantification of Ara h 6 was 0.024 ng/mL. Samples were tested in duplicate and ELISA 
analyses were performed twice. 
Parameters of intestinal permeability and integrity 
To assess intestinal permeability, levels of lactulose and L-rhamnose were analyzed in 
plasma sampled at t=0 and 60 minutes after intake of the peanuts and the dual sugar 
solution. 
To this end, 125 μL EDTA plasma was transferred to Eppendorf tubes equipped with a 3 kDa 
cut-off filter (Amicon Ultra 0.5 mL 3K, Millipore, Etten-Leur, The Netherlands) to remove the 
plasma proteins. The filter tubes were centrifuged for 30 minutes at 11000g at 4°C, and clear 
plasma filtrate was inserted in the pre-cooled sample processor (233 XL, Gilson, Middleton, 
WI, USA). Sugars were subsequently analysed by LC-MS as described [16]. Plasma 
lactulose/rhamnose (L/R) ratios were calculated from the 60 minutes plasma concentrations 
that were corrected for findings at baseline. 
FABP2 was measured as an acute marker of small intestinal epithelial integrity in EDTA 
plasma (1:1) with an in-house developed ELISA, as described [17]. 
Statistics 
All data is shown as mean ± standard deviation. The Wilcoxon matched-pairs signed rank 
test was applied to assess changes in AUC, maximal peak height, and time-to-peak analyses 
of serum levels of Ara h 6 between rest and exercise. Paired T-test was used to assess 
changes in lactulose, rhamnose, and L/R ratio between rest and exercise. Log transformation 
was applied in case of a deviation from a Gaussian distribution. For rhamnose and L/R ratio 
analyses, one person was excluded, because no rhamnose could be detected in one of the 
samples. Two-way ANOVA with Bonferroni’s multiple comparisons test was used to assess 
differences in FABP2 levels over time between rest and exercise. Pearson’s correlation 
coefficients were used to correlate the Ara h 6 parameters, intestinal permeability 
parameters, and FABP2 levels. All statistics were performed with GraphPad Prism (version 
6.07, GraphPad Software Inc., San Diego, CA, USA). Statistical significance was defined as a 
two-tailed P < 0.05. 
Results 
Exercise increases the levels of Ara h 6 in serum 
In rest, consumption of 100 grams of peanuts resulted in detectable serum Ara h 6 levels in 
each of the subjects (Figure 5.2A). These levels increased when the peanut consumption was 
followed by exercise, with large intra-individual differences (Figure 5.2B). One out of the ten 
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subjects did not show an increase in the peak level of Ara h 6 in exercise compared to rest 
(Figure 5.2C), while the other subjects did display an increase. Fold changes ranged from 0.7 
to 140.6 and the median peak Ara h 6 increased significantly from 0.22 in rest to 0.55 ng/mL 
during exercise (P = 0.01). The AUC calculated from time point t=0 to t=240 also changed 
significantly (P = 0.006) as the median AUC increased from 34.63 ng·min/mL in rest to 77.10 
ng·min/mL in exercise (Figure 5.2D). Here, individual fold changes ranged from 0.8 to 155.1 
fold. Compared to rest, the peak concentration of Ara h 6 in serum after peanut intake was 
reached earlier in time (P = 0.004) during exercise (Figure 5.2E).  
 
 
Figure 5.2. Ara h 6 levels in serum after peanut intake following Rest or Exercise 
Serum levels of Ara h 6 (Mean ± standard deviation) was measured 30, 60, 90, 120, and 240 min after the 
consumption of 100 grams of peanuts. This intake was followed by rest (A, red lines) or by exercise (60 minutes 
of cycling at 70% Wmax) (B, blue lines). For both conditions, individual peak levels (C), AUC (D), and time-to-
peak (E) were determined for rest (red circle) and exercise (blue square). * represents a P-value < 0.05; ** 
represents a P-value <0.01 
 
Exercise-induced effects on intestinal permeability and integrity markers 
Exercise-induced changes in integrity of the small intestine can be experimentally assessed 
by its permeability to small compounds, such as the inert sugar lactulose [18-21]; and by 
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circulating markers of intestinal integrity, such as FABP2 [22]. Plasma levels of lactulose 
increased significantly (P = 0.0009) when consumption of peanuts is followed by exercise 
compared to rest (Figure 5.3A). There was no difference in the absorption of L-rhamnose 
(Figure 3B), although one could see a tendency towards increased absorption (P = 0.08). 
Nevertheless, the calculated L/R ratios showed a significant increase (P = 0.04) as individual 
ratio fold changes ranged from 0.4 to 7.9-fold. These results suggest an increase in 
paracellular intestinal permeability when consumption of peanuts is followed by exercise.  
The effect of peanut consumption and endurance exercise on intestinal integrity was 
determined with circulating levels of FABP2. Figure 5.4 shows that plasma FABP2 levels were 
increased significantly after 30 minutes of exercise compared to the levels when the peanuts 
were consumed followed by rest. This increase became more pronounced after 60 minutes 
of exercise when compared to their values during rest. 
 
 
Figure 5.3. Lactulose and L-rhamnose sugar test for the analysis of intestinal permeability during Rest or 
Exercise 
Plasma levels of lactulose (A) and L-rhamnose (B) (Mean ± standard deviation) were measured after intake of 
the dual sugar solution followed by rest or exercise. From these, the Lactulose-over-l-rhamnose (L/R) ratio was 
calculated (C). * represents a P-value < 0.05; *** represents a P-value <0.001 
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Figure 5.4. Circulating fatty acid binding protein-2 (FABP2) levels upon exercise 
Fatty acid binding protein-2 levels (Mean ± standard deviation) were measured in plasma as a marker of 
intestinal integrity after 30 minutes or 60 minutes during rest (red circles) or exercise (blue squares). *** 
represents a P-value <0.001; **** represents a P-value <0.0001 
Correlations of Ara h 6 levels and intestinal permeability and integrity markers 
Pearson correlation coefficients were calculated to determine the correlation between the 
uptake of Ara h 6 and intestinal permeability as reflected by the uptake of lactulose. There 
was a strong correlation between the lactulose levels both with the peak levels of Ara h 6 (r 
= 0.77; P <0.0001; Figure 5.5A) and with the Ara h 6 AUC values (r = 0.70; P = 0.0005; Figure 
5.5B). The L/R ratio also correlated well with the peak levels of Ara h 6 (r = 0.66; P = 0.0007; 
Figure 5.5D) and the Ara h 6 AUC values (r = 0.60; P = 0.002; Figure 5.5E). The correlations 
between FABP2 levels after 60 minutes and lactulose levels (r = 0.58, P = 0.008; Figure 5.5C), 
L/R ratio (r = 0.54, p = 0.04; Figure 5.5F), Ara h 6 peak levels (r = 0.55, p = 0.01; Figure 5.5G), 
and Ara h 6 AUC (r = 0.60, P = 0.005; Figure 5.5H) were slightly lower, but still significant. 
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Figure 5.5. Correlation analysis of intestinal integrity markers and levels of Ara h 6 
Correlations are shown with the calculated Pearson’s correlation coefficients (r) and statistical significance. 
Correlations are made between the lactulose levels and the peak levels of Ara h 6 A) and the Ara h 6 AUC 
values (B), between the Lactulose-over-l-rhamnose (L/R) ratio and the peak levels of Ara h 6 (D) and the Ara h 6 
area under the curve (AUC) values (E), and between fatty acid binding protein 2 (FABP2) levels after 60 minutes 
and lactulose levels (C), L/R ratio (F), Ara h 6 peak levels (G), and Ara h 6 AUC (H). LOG = logarithm. 
 
Discussion 
The aim of the present study was to determine the effects of endurance exercise on 
intestinal permeability to the peanut-derived allergen Ara h 6 and to compare this with 
commonly used small molecule markers for intestinal permeability. Although exercise-
induced permeability towards potential allergens has been hypothesized to play a role in 
food-dependent exercise-induced anaphylaxis, the experimental evidence in humans is 
limited so far [23,24]. 
The current study shows a clear increase in the level of Ara h 6 as measured by ELISA in 
serum when peanut consumption was followed by exercise compared to the resting 
condition. Cycling at 70% Wmax also resulted in increased lactulose levels and consequently 
increased L/R ratios compared to rest. This outcome supports the hypothesis that exercise 
leads to increased paracellular permeability of the small intestine towards small molecules 
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[25]. The present study furthermore indicates a high correlation between the levels of Ara h 
6 and those of lactulose. It is therefore enticing to suggest a direct role for increased 
intestinal paracellular permeability in absorption of this allergen. There is a rather high 
variation in effect between the individuals and these differences appear to be similar for the 
effects on the levels of Ara h 6 as well as the L/R ratio. The causes for such inter-individual 
differences are not known. 
Although assumptions are often made, there is limited evidence besides our study for the 
passage of larger food-derived proteins and peptides across the intestinal barrier into the 
circulation [6,26-30], in particular in combination with exercise-induced permeability. 
Matsuo et al. [12] showed increased levels of circulating gliadin peptides upon exercise and 
intake of NSAIDs, but did not assess intestinal permeability. In recent studies, we used a 
strenuous exercise protocol involving both a glycogen depletion interval phase and an 
endurance exercise phase, which when compared to resting conditions, resulted in an 
increase in intestinal permeability to lactulose [31,32]. In the same model we detected an 
exercise-induced increase of the urinary recovery of the small casein-derived peptide 
betacasomorphin-7 [32]. However, the question for the uptake of larger dietary protein in 
the blood in combination with exercise remained. It has been demonstrated that the peanut 
protein Ara h 2, which together with Ara h 6, are the most potent peanut allergens [32,34], 
can be detected in breast milk after peanut ingestion [35], but detection in blood has not yet 
been proven and the effect of exercise not studied. Although peanut consumption and Ara h 
6 detection are included in the resting condition, performing an exercise-only intervention 
could additionally provide information on a possible interaction between peanut 
consumption and exercise on intestinal permeability. 
Because little is known on the absorption and clearance mechanisms of Ara h 6, or its 
derived peptides, in principle the increase in serum Ara h 6 peak levels could result from 
increased passage across the intestinal epithelial barrier, from lower clearance rate, or a 
combination of the two. However, given the effects seen on markers for intestinal 
permeability, and the strong correlation between those parameters, an increased passage 
seems conceivable. Theoretically, changes in intestinal digestion due to exercise could lead 
to changes in the detection of Ara h 6. It seems likely, however, that the allergen is crossing 
the barrier relatively intact. Digestion of Ara h 6 by pepsin and trypsin has been investigated 
in the past, showing that these only partially hydrolyse Ara h 6, resulting in two large 
peptides of around 4 to 5 kDa and 10 kDa in size, which are bound to each other by 
disulphide bridges [15,36,37]. We cannot claim with certainty whether it is the intact Ara h 6 
protein or these two bridged peptides that are appearing in the serum. These peptides are 
comparably reactive with intact Ara h 6 in the ELISA method that has been used [14]. The 
uptake of Ara h 6 and its immunoreactive fragments that are detected are physiologically 
relevant as these fragments are thought to contribute to the allergenicity of peanuts. Ara h 1 
and Ara h 3 are much more sensitive to digestion compared to Ara h 6 and Ara h 2, making 
them less able to trigger an immune response [36,38,39]. This study reports for the first time 
the detection of Ara h 6 in the blood. Although physiological levels of Ara h 6 are not exactly 
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known, the levels found in the current study is comparable to the levels of Ara h 2 in the 
circulation after peanut intake found by others [30,38].  
In most individuals, the highest Ara h 6 level in serum was found 120 minutes after peanut 
intake, which is similar in time as found in our prior study [14]. This peak, however, clearly 
shifted to earlier time points when the intake of peanuts was followed by intense exercise. 
This is possibly due to an increased gastric emptying rate of a solid meal during exercise [40]. 
Alternatively, this may be related to a forward shift in steady state [41] or changes in the 
route of epithelial transport.   
In the current study, a median peak level of 0.55 ng/mL during exercise reflects about 
0.0002% of the ingested dose of Ara h 6. This level lies within the suggested scope of antigen 
sampling, which takes place via transcytosis and sampling by dendritic cells. This process is 
estimated to occur at rates which are several orders of magnitude smaller than 0.1% of the 
administered dose [10,42]. These values, however, are mostly based on animal models or in 
vitro testing and only limited data in humans is available. The occurrence of food-dependent 
exercise-dependent anaphylaxis suggests that increased absorption during exercise is 
clinically relevant, as the threshold for allergic symptoms could be reached more easily at a 
similar intake. 
In conclusion, we show that endurance exercise after peanut consumption results in a clear 
increase in the serum levels of Ara h 6 after peanut consumption, which correlates strongly 
with increased intestinal permeability. This suggests that exercise has a profound effect on 
the amount of food-derived allergen crossing the epithelial barrier, also in healthy non-
sensitized individuals. This effect is possibly mediated by an increase in intestinal 
permeability. The current model could be used to screen for the potential health effects of 
novel protein sources under different physiological conditions. 
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Abstract 
Aim: In vivo studies suggest that maintenance of intestinal barrier function is dependent on 
mitochondrial ATP production. In this paper, we aim to provide mechanistic support for this 
observation using an in vitro model mimicking the oxidative in vivo situation. 
Methods: Human Caco-2 cells were cultured for 10 days in cell culture flasks or for 14 days 
on transwell inserts in either glucose or galactose containing medium. Mitochondria were 
visualized and cellular respiration and levels of oxidative phosphorylation (OXPHOS) proteins 
were determined. Cells were treated with CCCP, rotenone, or piericidin A (PA) for up to 30 
hours to induce cellular ATP depletion. Monolayer permeability was assessed with 
transepithelial electrical resistance (TEER) and fluorescein salt (FS) flux. Changes in gene 
expression of genes related to tight junctions were analysed. 
Results: Caco-2 cells cultured in galactose, but not glucose, containing medium showed 
increased mitochondrial connectivity, oxygen consumption rates and levels of OXPHOS 
proteins. Inhibiting mitochondrial activity with CCCP, rotenone and piericidin A (PA) resulted 
in a dose-dependent increased monolayer permeability (decrease in TEER, increase in 
fluorescein flux). In-depth studies with PA showed an almost six fold decrease in cellular ATP 
and altered gene expression profiles of tight junction proteins 1 and 2, occludin, and claudins 
1, 2 and 7. 
Conclusions: Well-functioning mitochondria are essential for maintaining Caco-2 cellular 
energy status and monolayer integrity when grown on galactose medium.  
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Introduction 
The gut is the major organ at the interface of the internal and external environment and 
plays an important role in nutrient uptake and metabolism, metabolic homeostasis and 
health. The splanchnic region is highly vascularized, which is pivotal to support the high 
metabolic demands of proper gut functioning [1]. The enterocytes lining the gut barrier are 
very sensitive to ischemic conditions [2]. Intestinal ischemia results in a state of 
inflammation and increased intestinal permeability [3, 4]. This suggests that oxidative energy 
metabolism plays an essential role in maintaining a gut barrier with high integrity. Several in 
vivo studies indirectly support this hypothesis, such as exercise studies that show an 
exercise-induced splanchnic hypoperfusion in combination with exercise-induced intestinal 
permeability [5]. Fructooligosaccharide supplementation in rats furthermore resulted in an 
increase in intestinal permeability [6]. Although in this study intestinal cellular energy status 
was not assessed, mitochondrial genes were highly regulated in a way similar to that 
induced by mitochondrial uncouplers. Finally, non-steroid anti inflammatory drugs are 
thought to induce intestinal permeability at least in part by uncoupling of mitochondria [7-
9]. These findings together suggest an essential role for mitochondrial ATP production in 
maintaining a gut barrier with high integrity.  
The Caco-2 cell line can be used to study the direct relation between mitochondrial ATP 
production and intestinal permeability. This human intestinal epithelial cell model, derived 
from a colon adenocarcinoma, demonstrates many in vivo intestinal functions and is the 
most widely used model to study the epithelial barrier function [10]. Good correlations have 
been reported between in vitro Caco-2 cell permeability and in vivo absorption in humans 
[11]. These cells, however, are routinely cultured in high glucose conditions thereby relying 
mainly on glycolysis for their ATP production. For several cell types it has been shown that 
an in vitro energy substrate switch from glucose to galactose results in a cellular phenotype 
relying more on mitochondrial ATP production [12-15]. Such an in vitro substrate switch is an 
improved representation of the in vivo situation and would enable one to study the role of 
mitochondrial ATP production in maintaining a healthy gut barrier. Therefore, our aim was 
to develop an in vitro intestinal permeability model mimicking the in vivo situation and, 
more crucially, to determine the role of mitochondrial ATP production in intestinal 
permeability. 
Material and methods 
Caco-2 cell culture 
The Caco-2 human colon cancer cell line was obtained from the American Type Culture 
Collection (ATCC HTB-37TM, Manassas, VA, USA). These cells were routinely grown in 75 
cm2 culture flasks (Corning, Amsterdam, NL) in high-glucose (25 mM) Dulbecco’s Modified 
Eagle’s medium (DMEM-glucose, Gibco, Breda, NL) supplemented with 100 U/L penicillin 
and 100 μg/L streptomycin (Gibco), 1 mM Na-pyruvate (Gibco), 2 mM glutamax (Gibco), 25 
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mM HEPES buffer (Gibco) and 10% heat-inactivated (56°C, 45 min) foetal bovine serum (FBS, 
HyClone, Thermo Scientific, Breda, NL). Caco-2 cells were cultured at 37ᵒC in a humidified 
atmosphere with 5% CO2 up to 80% confluency and then either subcultured or used for the 
experiments. For all experiments, Caco-2 cells with a passage number between 30 and 36 
were proliferated or differentiated using either DMEM-glucose or DMEM-galactose (glucose-
free DMEM (GIBCO) supplemented with 25 mM galactose as well as the other supplements 
as in DMEM-glucose. 
Mitochondrial respiration of Caco-2 cells  
Proliferating Caco-2 cells were cultured in DMEM-glucose or DMEM-galactose for 10 days 
after which oxygen consumption rate (OCR) was measured using 1.0 × 106 cells. OCR was 
measured at 37°C using polygraphic oxygen sensors in a two-chamber Oxygraph (Oroboros 
Instruments, Innsbruck, AT). Basal OCR was determined first followed by 1) leak OCR: 1 μM 
oligomycin (Sigma Aldrich), blocking complex V of the OXPHOS; 2) maximal OCR: titration 
with 1 μM carbonyl cyanide m-chlorophenylhydrazone (CCCP, Abcam Cambridge, UK), 
uncoupling OXPHOS; 3) non-mitochondrial OCR: 1 μM antimycin A (Sigma Aldrich) and 1 μM 
rotenone (ROT, Sigma Aldrich), blocking complex III and I, respectively. This experiment was 
performed six times.  
Caco-2 cells were also cultured in the XF96 cell culture microplate using DMEM-glucose or 
DMEM-galactose for 14 days to induce (semi-)differentiation. OCR was measured with the 
XF96 Extracellular Flux Analyzer (Seahorse Bioscience, Billerica, MA, USA). Basal OCR was 
determined first, followed by leak OCR: 15 μM oligomycin; maximal OCR: 1 μM carbonyl 
cyanide-p-trifluoromethoxyphenyl- hydrazone (FCCP, Sigma Aldrich); non-mitochondrial 
OCR: 25 μM antimycin A and 12.5 μM ROT. The FCCP concentration used was obtained from 
a titration experiment. The basal, leak, and maximal OCR values were corrected for non-
mitochondrial OCR. 
Mitochondrial visualization in proliferating Caco-2 cells 
To visualize the mitochondria, Caco-2 cells were seeded in 35 mm plastic dishes (Eppendorf, 
Nijmegen, NL) at 0.3-1.0 × 104 cells per cm2 in DMEM-glucose or DMEM-galactose and 
cultured for 10 days when 70% confluency was reached. Then, culture medium was replaced 
by phenol red-free DMEM (supplemented as DMEM-glucose or DMEM-galactose) with 
200nM MitoTrackerTM Green FM (Life Technologies, Breda, NL). After 30 min of incubation, 
the MitoTracker-containing medium was replaced by fresh DMEM-glucose or DMEM-
galactose and mitochondrial morphology was visualized with the EVOS® FL Color Imaging 
System (Life Technologies). 
Caco-2 cell differentiation and polarisation 
To induce differentiation and polarization, Caco-2 cells were seeded at a density of 1.0 × 105 
cells/cm2 in 24-well transwell inserts (0.4 μM diameter ThinCertsTM, Greiner Bio-one, 
Alphen a/d Rijn, NL) and differentiated for 14 days in DMEM-glucose or DMEM-galactose. 
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Culture medium was changed three times a week and transepithelial electrical resistance 
(TEER) was monitored using a MilliCell-ERS voltohmmeter (Millipore, Etten-Leur, NL). Only 
the monolayers with TEER values exceeding 200 Ω × cm-2 were used for Caco-2 monolayer 
permeability experiments and for determination of OXPHOS protein levels and RT-qPCR 
gene expression analysis. 
Western blotting to determine OXPHOS protein levels 
14-days differentiated Caco-2 cells were washed with ice-cold HBSS, lysed and sonicated in 
50 mM TRIS (pH 7.4) supplemented with 1% Triton (Sigma Aldrich) and 10% protease 
inhibitor (P8340, Sigma Aldrich). Experiments were performed in triplicate. Protein 
concentrations were determined with the Bio-Rad DC colorimetric protein assay (Bio-Rad 
laboratories, Veenendaal, NL) according to manufacturer’s protocol. Protein samples were 
heated at 50°C for 5 min, separated (30 μg protein per sample per lane) by SDS-PAGE using 
12% acrylamide gels and finally transferred to an Immobilon® transfer membrane 
(Millipore). Five individual proteins representing the five different OXPHOS complexes 
(NDUFB8 for Complex I; SDHB for Complex II; UQCRC2 for Complex III; COX II for Complex IV; 
ATP5A for Complex V) were detected (incubation overnight at 4°C) with total OXPHOS 
human antibody cocktail (1:1000, Ab110411, Abcam). Anti-beta-actin antibody (1:1000, 
Ab8227) was used as a loading control. Bound primary antibodies were visualized using 
IRDye 800CW goat anti-mouse IgG secondary antibody (1:10,000; LI-COR Biosciences Inc., 
Lincoln, NE, USA). Blots were scanned with LI-COR’s Odyssey Infrared Image System. 
Caco-2 monolayer permeability experiments 
14-days differentiated Caco-2 cells were used for monolayer permeability experiments, 
which were all performed in triplicate. Caco-2 cells were incubated with varying 
concentrations of either vehicle (96% EtOH), CCCP (mitochondrial uncoupler, 0-1-2-3-4-5 
μM), rotenone (ROT, Complex I inhibitor, 0-50-100-200 nM), and Piericidin A (PA, Complex I 
inhibitor, 0-50-100-200 nM; Cayman Chemicals, Ann Arbor, MI, USA) for 27 hours, 30 hours, 
and 42 hours, respectively. Changes in TEER were followed over time to determine 
permeability of the Caco-2 monolayer. Apical medium was harvested to determine 
cytotoxicity with the Pierce LDH Cytotoxicity assay kit (Thermo Scientific), according to the 
manufacturer’s instructions.  
100 ug/mL fluorescein (Sigma Aldrich) was added to the apical medium of Caco-2 cells 
incubated with vehicle (96% EtOH) or 200 nM PA for 24 hours prior to harvesting the 
basolateral medium at different time points. Caco-2 cells incubated with vehicle (96% EtOH) 
or 200 nM PA were also harvested at different time points to determine cellular energy 
status and to isolate RNA for gene expression analysis. 
HPLC determination of cellular energy status of Caco-2 cells 
14-days differentiated Caco-2 cells were incubated with vehicle (96% EtOH) or 200 nM PA 
and then harvested at several time points to measure cellular levels of ATP with high 
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pressure liquid chromatography analysis, adapted from Di Pierro et al. [16]. All samples were 
deproteinized by mixing with 100 μL 7% perchloric acid, 125 μL 1 M KOH and 75 μL 0.1 M 
phosphate buffer pH 6.5 followed by centrifugation for 10 min at 14000g at 4°C. Supernatant 
was snap-frozen in liquid nitrogen and stored at -80°C until further analysis. Twenty-five μL 
of the supernatant was analyzed on a HPLC system (LaChrom Elite, Merck-Hitachi) with UV 
detection at 254 nm (Kratos). The chromatography was performed on an HPLC C18 column 
(Aqua; 150×4.6 mm, 5 μm, Phenomenex) using a gradient elution with two mobile phases. 
Mobile phase A consisted of 0.1 M phosphate buffer pH 6.0 and mobile phase B consisted of 
0.1 M phosphate buffer pH 6.0 / methanol (60/40). The gradient, at a flow rate of 1 mL/min, 
was as follows: 0-5 min isocratic at 0% mobile phase B; 5–16 min linear gradient from 0% to 
22% B; 16–25 min linear gradient from 22% to 60% B; 25–27 min linear gradient from 60% to 
100% B; 27-28 min isocratic at 100% B; 28-29 min linear return from 100% to 0% B; 29-35 
min isocratic at 0% B, making a total run time of 35 min. Peaks were integrated with Clarity 
Lite software (DataApex, Prague, Czech Republic) and levels of cellular ATP were calculated 
using calibration curves made with commercially available standard (Sigma Aldrich). 
RT-qPCR gene expression analysis 
Total cellular RNA was isolated from 14-days differentiated Caco-2 cells incubated with 
vehicle (96% EtOH) or 200 nM PA at different time points using the Qiagen RNeasy Kit 
(Qiagen, Westburg, Leusden, NL) in combination with the on-column DNase I (Bio-Rad) 
treatment, according to the manufacturer’s instructions. RNA quantity was checked with the 
Nanodrop spectrophotometer (IsoGen Life Science, Maarssen, NL) and RNA integrity was 
checked by capillary zone electrophoresis (Experion, Bio-Rad). RNA of all individual samples 
(n=6 per condition) was reverse transcribed using the iScript cDNA synthesis kit (Bio-Rad). 
Gene expression measurements were performed in a 25 μL reaction mix containing iQ SYBR 
Green Supermix (Bio-Rad) using the CFX96 Real-Time System (Bio-Rad). Target and reference 
genes, gene symbols and primer sequences are shown in Table 6.1. Reference genes were 
selected based on stability. The expression of the gene of interest was normalized against 
the geometrical mean of the reference genes with the CFX software (Bio-Rad). 
Statistics 
The average values are presented as mean ± SD. All statistical analyses were performed in 
Graphpad Prism (Version 6.07). Student T-tests were applied to assess changes in OCR and 
the different OXPHOS complex protein levels between Caco-2 cells cultured in DMEM-
glucose and those cultured in DMEM-galactose. Student T-tests were also applied to assess 
changes in LDH release, cellular ATP levels, fluorescein flux, and tight junction gene 
expression between Caco-2 cells treated with CCCP, PA or ROT and their corresponding 
controls. In case data were not normally distributed, data were log transformed (TJP1, TJP2 
and CLDN2). Gene expression of TJP1 was also after log transformation not normally 
distributed and a Mann Withney U test was performed instead. One-way ANOVA with 
Sidak’s multiple comparisons post-hoc testing was applied to assess differences in sucrase-
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isomaltase gene expression between Caco-2 cells differentiated in DMEM-glucose and those 
differentiated in DMEM-galactose. Statistical significance was defined as a two-tailed p < 
0.05. 
 
Table 6.1. Primer sequences of reference genes and genes of interest 
Reference genes Forward primer 5’-3’ Reverse primer 5’-3’ 
Beta-actin (ACTB) CTGGAACGGTGAAGGTGACA AAGGGACTTCCTGTAACAATGCA 
Beta-2-microglobulin (B2M) TGCCGTGTGAACCATGTG GCGGCATCTTCAAACCTC 
Transmembrane protein 14C CCGCTTGTTTTCTGCAGGTG CACGCTGCCTGCTTTTACATAG 
Glutaminyl-tRNA synthetase TAAGTGACCTGAACCTGGCATC GACGCTCAAACTGGAACTTGTC 
Genes of interest Forward primer 5’-3’ Reverse primer 5’-3’ 
Sucrase-isomaltase (SIM) GAGGACACTGGCTTGGAGAC ATCCAGCGGGTACAGAGATG 
Tight junction protein 1 (TJP1) GGGAACAACATACAGTGACGC CCCCACTCTGAAAATGAGGA 
Tight junction protein 2 (TJP2) GGAGGATGTGCTTCATTCG GGCCTCTTGACCACAATAG 
Occludin (OCLN) CCCATCTGACTATGTGGAAAGA AAAACCGCTTGTCATTCACTTTG 
Claudin 1 (CLDN1) TTTCCTGCTACAACAATCCTCTCC GTTGTTTTTCGGGGACAGGAAC 
Claudin 2 (CLDN2) CTCCCTGGCCTGCATTATCTC ACCTGCTACCGCCACTCTGT 
Claudin 7 (CLDN7) CTGCAAAATGTACGACTCGGTG GCAAGACCTGCCACGATGAAAA 
Results 
Galactose culturing switches Caco-2 cells towards a more oxidative metabolic phenotype 
To establish the relation between mitochondrial ATP production and intestinal permeability 
it is essential that ATP production in the culture system is dependent on mitochondria and 
not on glycolysis only. This is not the case when Caco-2 cells are cultured in glucose-rich 
culture medium (data not shown). Therefore, we first investigated whether a switch to high-
galactose (25mM) medium (DMEM-galactose) stimulates mitochondrial ATP production as 
described previously for other cell types [12].  
Caco-2 cells show an increased density and an increase in branching of the mitochondrial 
network when grown on DMEM-galactose compared to DMEM-glucose (Figure 6.1A). In line 
with this finding, protein levels of subunits of the five different OXPHOS complexes were 
increased on DMEM-galactose compared to DMEM-glucose (Figures 6.1B and C). The largest 
increase was seen for complex I, followed by complex IV and II. Functionally, Caco-2 cells 
grown on DMEM-galactose showed increased basal and maximal OCR. These effects were 
similar for undifferentiated Caco-2 cells, as measured with the high-resolution oxygraph with 
undifferentiated cells (Figure 6.1D), and semi-differentiated Caco-2 cells, as measured with 
the Seahorse XF96 (Figure 6.1E). 
Caco-2 cells differentiated on DMEM-galactose showed higher absolute TEER values 
(approximately 300 Ω·cm2 vs 200 Ω·cm2) and a higher increase in gene expression of the 
brush border enzyme sucrase-isomaltase (about 8-fold for glucose vs about 14-fold for 
galactose, Figure 6.1F), compared to DMEM-glucose. To provide a first link between 
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mitochondrial ATP production and Caco-2 monolayer permeability, indicated by TEER values, 
we uncoupled the mitochondria using CCCP, which is also used to determine maximal OCR. A 
dose-dependent decrease in TEER by CCCP was seen in 14-days differentiated Caco-2 cell 
monolayers when cultured in DMEM-galactose after 12 hours of incubation (Figure 6.1G). At 
12 and 15 hours of CCCP incubation, LDH release was not increased indicating the absence of 
CCCP-induced cytotoxicity (Figure 6.1H).  
Altogether, these findings indicate that Caco-2 cells cultured in DMEM-galactose switched to 
a more oxidative metabolic phenotype and became dependent on mitochondrial ATP 
production, which inhibition results in decreased Caco-2 monolayer permeability. Next to an 
effect on mitochondrial OXPHOS uncoupling, CCCP also may exert nonspecific effects in the 
cell [17, 18]. Therefore, we decided to continue the experiments with a different, more 
targeted method to obstruct mitochondrial ATP production by inhibiting complex I, which 
showed the largest increase in protein levels when Caco-2 culture medium was switched 
from DMEM-glucose to DMEM-galactose.  
 
Rotenone and Piericidin A increase permeability and decrease cellular energy status of 
Caco-2 monolayer grown in DMEM-galactose 
In the Caco-2 monolayers ROT induced, in a concentration-dependent manner, first an 
increase followed by a decrease in TEER when cultured in DMEM-galactose, but not DMEM-
glucose (Figure 6.2A). However, ROT has been shown to have the potency to destabilize 
microtubules [19], which next to the actin cytoskeleton have been indicated to be critical in 
maintaining tight junctions and thus the integrity of the epithelial barrier [20]. These off-
target effects have not been related to PA and therefore this Complex I inhibitor was used in 
the remainder of this study. Similar to ROT, PA induced in a concentration-dependent 
manner first an increase and then a decrease in TEER of Caco-2 monolayers cultured in 
DMEM-galactose, but not in DMEM-glucose (Figure 6.2B). The lowest concentration of PA of 
50 nM was insufficient to induce a decrease in TEER, while 100 nM of PA resulted in a 
delayed but similar pattern as 200 nM of PA, which showed the largest effects on Caco-2 
monolayer permeability without observed cytotoxicity (Figure 6.2F). It furthermore resulted 
in a significant reduction in the cellular energy status as reflected by decreased levels of ATP, 
already at the point where TEER was still increased, but more pronounced at the point 
where TEER was decreased (Figure 6.2D). The increase in Caco-2 monolayer permeability 
was also shown by an increased amount of fluorescein passing the monolayer (Figure 6.2E). 
These results suggest that an increase in Caco-2 monolayer permeability is a result from a 
decreased cellular energy status by inhibiting mitochondrial ATP production. 
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Figure 6.1. Oxidative metabolic characterization of Caco-2 cells grown on glucose and galactose substrate 
Caco-2 cells were grown in DMEM-glucose and DMEM-galactose for 10 days, after which (A) mitochondrial 
structures, (B) and (C) levels of OXPHOS complexes, (D) basal, leak, and maximal oxygen consumption rates 
were determined. Caco-2 monolayers were semi-differentiated in DMEM-glucose and DMEM-galactose for 14 
days after which (E) basal, leak, and maximal oxygen consumption rates were determined. 14-days 
differentiated Caco-2 monolayers grown in DMEM-glucose and DMEM-galactose were tested for (F) their 
sucrose-isomaltase gene expression; Gene expression was normalized with the mRNA gene expression of beta-
actin and beta-2-microglobulin. The 14-days differentiated Caco-2 monolayers were incubated with CCCP (0-1-
2-3-4-5 μM) after which (G) the transepithelial electrical resistance (TEER) and (H) the cytotoxicity as assessed 
by the release of lactate dehydrogenase (LDH) were followed over time. The results are expressed as a mean ± 
SD. The * symbol indicates statistical significance of P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001. 
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Figure 6.2. Effects OXPHOS Complex I inhibition on differentiated Caco-2 monolayers cultured in DMEM-
glucose and DMEM-galactose 
14-days differentiated Caco-2 monolayers were incubated with vehicle (96% EtOH) or rotenone (ROT; 50-100-
200 nM) or Piericidin A (PA; 50-100-200 nM) after which TEER was followed over time, (A) and (B) show 
representative examples of a single experiment and (C) the average of three independent experiments. 14-days 
differentiated Caco-2 monolayers grown in DMEM-galactose were incubated with vehicle (96% EtOH) or 200 
nM PA, after which (D) cellular ATP status, (E) fluorescein (FS) passage from the apical to the basolateral side of 
the monolayer, and (F) cytotoxicity by lactate dehydrogenase (LDH) release were determined. The results are 
expressed as a mean ± SD. The * symbol indicates statistical significance of P < 0.05, ** P < 0.01, and **** P < 
0.0001. 
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Piericidin A alters the expression of tight junction genes in Caco-2 monolayers 
mRNA gene expression analysis of tight junction genes was performed at the point of the 
clear increase (150-200%) and the clear decrease (40-60%) in TEER of the DMEM-galactose-
cultured Caco-2 monolayers treated with 0 (control) or 200 nM PA. When the TEER was high, 
after approximately 15 hours of PA treatment (Figure 6.2C), the gene expression of tight 
junction protein 1 (TJP1; P = 0.04), occludin (OCLN; P = 0.001) and claudin 1 (CLDN1; P = 
0.003) was significantly increased in Caco-2 cells treated with 200 nM PA as compared to 
control. In contrast, the gene expression of tight junction protein 2 (TJP2) was unchanged, 
while the expression of claudin 2 (CLDN2; P = 0.003) and claudin 7 (CLDN7; P = < 0.0001) 
were significantly decreased upon PA treatment compared to the control (Figure 6.3). When 
TEER was low, after approximately 24 hours of PA treatment (Figure 6.2C), these outcomes 
were more pronounced for TJP1 (P = 0.002), OCLN (P = < 0.0001) and both CLDN2 (P = < 
0.0001) and CLDN7 (P = < 0.0001). However, at this point the gene expression of CLDN1 
showed merely a trend (P = 0.06), while gene expression of TJP2 became significantly 
increased (P = 0.02 ) upon PA treatment as compared to the control (Figure 6.3).  
 
 
Figure 6.3. Gene expression of tight junctions in Caco-2 monolayers upon PA treatment 
14-days differentiated Caco-2 monolayers grown in DMEM-galactose were incubated with vehicle (96% EtOH) 
or 200 nM Piericidin A (PA), after which mRNA gene expression of tight junction protein 1 (TJP1), tight junction 
protein 2 (TJP2), occludin (OCLN), claudin 1 (CLDN1), claudin 2 (CLDN2) and claudin 7 (CLDN7) between the 
moment when the transepithelial resistance (TEER) of the monolayer was high (High TEER) and low (Low TEER) 
were determined. Gene expression was normalized with the mRNA gene expression of the beta-2-
microglobulin, transmembrane protein 14C, and glutaminyl-tRNA synthetase. The * symbol indicates statistical 
significance of P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001. 
Discussion 
In this study, we newly developed a Caco-2 cellular model that for its energy production was 
dependent on mitochondrial ATP production. To achieve this, a substrate switch from 
DMEM-glucose to DMEM-galactose was applied, based on previous experience with other 
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cell lines [12-15]. This model provides a situation more similar to the in vivo situation. Data 
from this model support that intestinal permeability is highly dependent on mitochondrial 
ATP production. Inducing mitochondrial dysfunction by either uncoupling or inhibition of 
OXPHOS function resulted in a decrease in cellular ATP levels, followed by a decrease in TEER 
and an increase in the paracellular flux of the fluorescein marker. This supports other studies 
that observed a relation between cellular ATP levels and cell monolayer permeability [21-
25]. However, these models lack the representation of the in vivo situation, because they 
were cultured in high glucose medium. Caco-2 monolayers were subsequently incubated 
with 2-deoxyglucose, inhibiting glycolysis, or a combination of 2-deoxyglucose and antimycin 
A, inhibiting both glycolysis and OXPHOS, leading to a decrease in cellular ATP levels as well 
as an increase in monolayer permeability [24, 25]. Similar results were also found in Caco-2 
cells treated with indomethacin, with or without ROT, both of which have been shown to 
inhibit OXPHOS Complex I [26]. The majority of these studies completely blocked glycolysis, 
OXPHOS (by inhibiting complex III), or both, which is a stringent inhibition of energy 
production. This is supported by the fact that effects were already observed within minutes. 
Importantly, very high levels ( >200 times higher than levels used with our model) of 
OXPHOS inhibitors were used [25, 27], at doses that have been shown to induce show severe 
off-target effects that could lead to destabilization of microtubules [19], high oxidative stress 
[27], and Rho-GTPase-induced changes in tight junction or cytoskeleton structure [28, 29]. As 
ROT also showed off-target effects at very low concentrations, we included PA, which does 
not display these of target effects [28], and we decided to test the minimal concentration of 
ROT and PA that maximally reduced cellular ATP status and TEER, without apparent effects 
on cell damage/death. It can be concluded from the absence of any effect in the Caco-2 
monolayers cultured in glucose-containing medium that both ROT and PA at these doses had 
no described off-target effects and that Caco-2 monolayers cultured in glucose-containing 
medium did not depend on their mitochondria for their ATP production.  
Surprisingly, our studies showed first a dose-dependent increase in the TEER, followed by a 
similar dose-dependent decrease in TEER, independent of whether the Caco-2 monolayers 
were treated with CCCP, ROT, or PA. We speculate that since TEER is based on ion 
permeability of the monolayer, it may indicate a response of the cells that limits ion fluxes. 
The increase in TEER can therefore be suggested to reflect an initial defence mechanism of 
the intestinal epithelial cells to energy stress, whereby ATP-dependent ion channels, such 
Na+,K+-ATPase, are shutdown [25]. This may be part of a cellular energy conservation 
strategy since Na+,K+ATPase constitutes the major component of basal metabolic rate [1] 
and is fuelled by mitochondrial ATP [30]. Whether the observed increase in TEER would 
reflect an actual decrease in monolayer permeability for small molecules or only ion 
permeability cannot be assessed with the flux of fluorescein or labelled dextrans, as this 
measurement is only sensitive enough to determine an increase in monolayer permeability. 
Next, we aimed at obtaining a first insight in the underlying mechanism for these observed 
patterns in TEER by analysing the expression of several tight junction genes in Caco-2 
monolayers incubated with PA. There are many proteins involved in the formation of the 
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tight junctions, serving various functions. The tight junction proteins together with OCLN 
mainly support and stabilize the structure of the tight junctions [31]. The observed increases 
in gene expression of TJP1, TJP2, and OCLN could be a compensatory mechanism of the 
Caco-2 cells, in an attempt to stabilize and protect the structure of the tight junctions [32]. In 
contrast, the claudins have shown to play an essential role in the actual paracellular 
permeability, by forming barriers that tighten or pores that open the paracellular pathway 
for selective molecules [33]. CLDN1 and CLDN7 have been mainly described to tighten the 
junctions by barrier formation [34-36], while CLDN2 opens the junction by pore formation 
[35, 37, 38]. The upregulation of CLDN1 and downregulation of CLDN2 could reflect a first 
defense mechanism to prevent an increase in intestinal permeability. Only the 
downregulation of the gene expression of ‘tightening’ CLDN7 is not consistent with a 
protective response. It should be noted that changes in gene expression are inconclusive, 
since functionality will be determined by changes in levels and localisation of the different 
proteins. Indeed changes in tight junction protein localisation have been associated with 
monolayer permeability [39]. It has been shown that, in Caco-2, MDCK and glomerular 
epithelial cell monolayers, antimycin A-induced or ROT-induced ATP depletion altered the 
distribution of TJP1 and OCLN, without affecting their protein levels [21, 22, 40]. Since 
redistribution of these tight junction proteins affect their interactions with the cytoskeleton 
[23], these effects could possibly be caused by off-target effects rather than decreased ATP, 
but this remains to be elucidated. 
The partial oxygen pressure of the small intestine is sufficient, but low. This renders the 
small intestine very sensitive to a decrease in supply of oxygen or an increase in demand 
with concommitent increase in infection and inflammation [41]. Depency on oxygen supply 
also explains the strong intestinal response to ischemia [2-4]. The small intestinal barrier is 
thus, at least partly, dependent on aerobic, i.e. mitochondrial energy production. This is not 
the case when the Caco-2 monolayers are grown in DMEM-glucose. Our DMEM-galactose 
Caco-2 model therefore provides a physiologically more relevant alternative. This oxidative 
Caco-2 model offers the possibility to study the mechanism underlying intestinal 
permeability as observed during in vivo situations.  
This model could therefore be an important tool to unravel possible underlying mechanisms 
of intestinal permeability. Next to normal physiological conditions, such as during endurance 
exercise, intestinal permeability is also observed in many disease-related situations [42]. It is 
attractive to think that by studying intestinall permeability in detail using this Caco-2 model 
could potentially offer therapeutic targets to improve disease states.  
Conclusion 
In conclusion, mitochondria play an essential role in maintaining an intestinal barrier with 
high integrity. This is supported by the dependency on mitochondrial ATP production of 
Caco-2 monolayers grown on DMEM-galactose, which is mimicking the in vivo situation by 
showing a more oxidative metabolic phenotype that is responsive to mitochondrial 
dysfunction.  
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Aims 
To better understand intestinal permeability towards proteins, the first aim of the research 
presented in this thesis was to examine the effect of a widely experienced physiological 
challenge, exercise, on the permeability of the intestine to dietary proteins and peptides. In 
proof-of-concept studies, the intestinal permeability for small inert sugars was compared 
with that for dietary proteins and peptides, obtained from 2 different dietary sources. The 
effect of exercise on permeability and on a variety of systemic responses related to the 
intestine were studied.  
The second aim was to determine the role of oxidative metabolism in maintenance of 
intestinal epithelial integrity. This information could contribute to explain in vivo 
observations and is a first step towards the development of a physiologically relevant human 
in vitro intestinal epithelial model to study intestinal permeability.  
This last chapter will reflect on the main outcomes of the previous chapters. Next, some 
strengths and weaknesses of the studies performed will be placed in the broader context of 
methodological considerations for future study designs. A hypothesis will be given for the 
mechanism of exercise-induced increase in intestinal permeability. Implications of the 
findings and directions for future research in intestinal permeability will also be given. 
Finally, some general conclusions will be drawn. 
 
Main findings 
• Endurance exercise induced intestinal permeability to inert sugar molecules. 
• The casein-derived peptide betacasomorphin-7 crossed the intestinal barrier to a 
greater extent following exercise, as compared to rest 
• The peanut-derived allergen Ara h 6 crossed the intestinal epithelial barrier to a 
greater extent when consumption was followed by endurance exercise as compared to 
rest, which correlated well with the increased uptake of lactulose. 
• Replacing the energy substrate glucose by galactose induced a switch to a more 
aerobic phenotype in Caco-2 cells, which made them susceptible to mitochondrial 
dysfunction.  
• Mitochondrial dysfunction in galactose-cultured Caco-2 monolayers leads to ATP 
depletion and an increase in intestinal permeability. 
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Lessons learned from in vivo studies - Methodological considerations for 
future design of studies. 
Exercise as a challenge to increase intestinal permeability 
We know from literature that endurance exercise is able to induce an increase in intestinal 
permeability towards inert sugar markers. Most studies focused on the effect of running and 
cycling. Exercise-induced permeability is measured with the paracellular passage of an inert 
disaccharide such as lactulose. This is, however, a relatively small macromolecule and the 
question remained to which extent larger macromolecules such as dietary proteins and 
peptides are also able to cross the intestinal barrier following exercise. Food-Dependent 
Exercise-Induced Anaphylaxis (FDEIA) is a rare condition in which individuals only respond to 
the allergic food when ingested in combination with exercise [1, 2] or low doses of aspirin [3, 
4]. This suggests that exercise can indeed lead to an increased intestinal permeability to 
dietary proteins. Although the assumption is often made, evidence from studies in humans 
on the uptake of intact protein without exercise is scarce and incomplete [5], even less 
information is available in combination with exercise. Husby and colleagues [6-8] and 
Paganelli and colleagues [9, 10] showed in several studies that allergens can be detected in 
their intact form in the blood after food consumption in healthy individuals, and it was 
shown that coeliac disease may lead to increased uptake of these allergens, which supports 
that intestinal permeability could be an underlying cause. It has been suggested that more of 
an antigen leaks into the circulation upon acute exercise, but this was seen in sensitised mice 
and not in unsensitised mice [11]. These measurements were indirect as no analyses were 
performed in serum and exercise-induced permeability was not determined. In contrast, 
Matsuo and colleagues [12] did show an increase in circulating levels of dietary (gliadin) 
peptides during exercise as compared to rest, also in healthy individuals. However, they did 
not assess intestinal permeability and therefore could not speculate on possible routes of 
uptake.  
In my thesis research, I performed two proof-of-concept studies that provided the evidence 
that endurance exercise indeed results in an increased amount of dietary protein and 
peptides in the circulation, coinciding with an increase in intestinal permeability as 
measured with several markers. With the studies performed in this thesis, we cannot 
conclude which mechanism accounted most for the increase in intestinal permeability to 
peanut allergen: increased transcellular transport or decreased intestinal integrity due to 
changes in tight junctions (increasing paracellular transport) or loss of epithelial cells. On the 
one hand, the fact that the increase in peanut allergen uptake was highly correlated with the 
increase in the uptake of the paracellular marker lactulose suggests that increased uptake of 
dietary proteins and peptides during exercise is mediated via paracellular transport. On the 
other hand, a decrease in cell integrity may also be involved as the increase in peanut 
allergen uptake also correlated with the release of fatty acid binding protein-2 (FABP2), a 
direct marker for epithelial cell damage which will be discussed in more detail later. FABP2, 
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however, also correlated well with the uptake of the sugars, which makes it difficult to 
interpret what is actually directly or indirectly related to each other.   
 
 
In any case, exercise seems to compromise intestinal integrity and thereby increase 
intestinal permeability to dietary proteins. It has been shown in vitro that peanut allergens 
are able to cross human intestinal Caco-2 cell monolayers [13]. The peanut allergens altered 
tight junction protein localisation in Caco-2 monolayers, which possibly facilitated uptake via 
the paracellular route. To confirm whether this holds true also in vivo, animal models in 
combination with exercise challenges could be used in which the small intestine can be 
harvested and studied in more detail for its permeability as well as morphology and tight 
junction protein localisation. Next to this, small intestine-specific knockout and transgenic 
animals could be developed to study the role of specific factors in intestinal permeability. A 
system that combines Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) 
with Cas 9, an RNA-guided DNA cleaving enzyme, can be used to develop human cell models 
and animal models with tissue-specific DNA edits. This very recently discovered and 
developed system is a breakthrough in genome engineering, offering a relatively efficient 
way to very specifically edit genomes and adjust gene regulation [14]. Much of this 
technology has been developed and reviewed by the laboratories of Doudna [14-16] and van 
der Oost [17, 18]. By blocking or activating processes involved in transcellular transport, 
intestinal integrity, or mitochondrial oxidative metabolism, their potential role in exercise-
induced intestinal permeability can be studied in more detail. 
 
“Intestinal permeability: 
The ability of compounds to cross the intestinal epithelial barrier.” 
 See Figure 1.2  
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The sugar test as a marker for intestinal permeability 
It is important to choose the right method to assess intestinal permeability [19]. In human 
studies, intestinal permeability is measured by the intestinal epithelial passage of at least 
two marker molecules into the blood or urine. As already discussed in the general 
introduction, several markers have been proposed, and most often the lactulose/rhamnose 
or the lactulose/mannitol dual sugar test is applied, which are currently considered to be the 
golden standard in clinical practice [19]. 
In contrast to certain disease models, in which intestinal permeability is often chronically 
increased, there is only a short window to measure an increase in intestinal permeability 
induced by a physiological challenge such as endurance exercise. Consequences of exercise 
may be also less apparent than disease-induced permeability. Therefore, it is important that 
changes in intestinal permeability with the sugar test can be detected with high sensitivity. 
In this regard, several factors are important in the study design of exercise interventions: 
 
First, the timing of the ingestion of the sugar test solution is an important factor that can 
affect outcome. In literature, different timings of consumption of the sugar solution have 
been applied; before, during, and after the onset of exercise. During our first study (Protégé 
Study, chapters 2 and 3), the participants were instructed to ingest the sugar solution 
immediately  after they finished the endurance exercise. The measured changes in intestinal 
permeability were not as large as expected and in fact, the lactulose/rhamnose ratio was 
increased due to lower uptake of rhamnose rather than increased uptake of lactulose. 
Several explanations can be suggested for the  limited exercise-induced permeability. First, 
the participants were highly trained and their intestine may have been adapted to the 
exercise-induced stress. Second, the endurance exercise of 50% Wmax may not have been 
intensive enough to elicit the expected response. Although this level of exercise was 
perceived by the participants as being very heavy in combination with the glycogen 
depletion exercise that was done as part of the protocol on the previous evening, it may 
have not been strenuous enough to induce effects on intestinal permeability. A third 
explanation could be that the glycogen depletion exercise may have had a protective pre-
conditioning effect on the endurance exercise. Unfortunately, the effect of each of the two 
exercise phases within the dual exercise intervention were not assessed separately, to 
obtain clarity. Finally, permeability may be only increased during exercise and be restored 
shortly thereafter. This explanation is in line with the concept that oxygen and nutrient 
drainage towards muscle and away from the intestine induces permeability [20].  
During the second study (PEANUTS Study, chapter 5), the participants were instructed to 
ingest the sugar solution at the start of the exercise protocol. In this setting we found a clear 
exercise-induced increase in intestinal permeability for each of the participants. Although 
several factors were different from the first study, such as untrained individuals instead of 
highly trained individuals and a single exercise intervention at 70% Wmax instead of a dual 
exercise intervention ending with 50% Wmax, we believe that the timing of the intake of the 
sugar solution may have played a major role in finding much more pronounced effects in 
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exercise-induced permeability. When we look at direct effects of exercise on the small 
intestine, the marker of small intestinal epithelial damage, fatty acid binding protein-2 
(FABP2) appears to be released into the blood stream mainly during the exercise and its 
levels drop rapidly when the exercise is finished [20-22]. Directly after the exercise has 
finished, the recovery phase starts, likely also rapidly attenuating the exercise-induced 
permeability. This strengthens the notion that permeability needs to be detected during the 
challenge, in this case exercise, and that it is more difficult to detect intestinal permeability 
when the sugar test is applied directly after the exercise rather than just before or during the 
exercise. 
 
A second factor to consider in the application of the sugar test is at which time point after 
consumption and in which biological fluid the sugars should be analysed. During the first 
study we measured the sugar levels in both a plasma sample taken after 1 and 5 h urine. Due 
to practical feasibility, urine was pooled over a period of 5 hours, but the analysis of the 
plasma taken after 1 h showed to be a more sensitive indicator for the exercise-induced 
changes in uptake of the sugars [20, 21]. Collecting urine at set time points proved to be 
more difficult than expected, but 5 hours of urine collection may have been too long, as it 
has been shown that the sugar test in 2 h urine is more sensitive than in 5 h urine [23]. 
Overall, even though slightly more invasive with regard to sample collection, we would 
recommend the detection of the sugar levels in plasma over detection in urine. If urine is 
used, then it seems best to limit the time window of collection to 2 hours.  
 
A third factor to consider in the application of the sugar test is the validity of the markers. 
Even though used frequently, the inertness of lactulose in the small intestine is under 
debate. Lactulose is fermented by the microbiota in the large intestine and therefore only 
reflects permeability of the small intestine [24]. Fermentation of lactulose, however, could 
also take place in the small intestine. Although this is generally considered only to be of 
importance in case of small intestinal bacterial overgrowth, for which the lactulose breath 
test has been developed for detection [25], also the small intestine of healthy individuals 
contains a considerable amount of microbiota able to ferment carbohydrates [26]. Inter-
individual differences in microbiota can possibly lead to a large variation in outcome, 
decreasing the power for statistics. This is why it is important that the sugar test contains a 
monosaccharide, such as rhamnose or mannitol, as a reference of which the uptake is 
unaffected by changes in intestinal permeability, but is similarly affected as lactulose by 
other potential modulatory factors such as bacterial degradation. If the treatment affects 
these modulatory factors, the ratio of the two sugars gives a more reliable measure of 
intestinal permeability than when lactulose is used alone [27]. The drawback of rhamnose 
and mannitol in the analysis is that these monosaccharides are often also detected in 
significant levels in plasma and urine at baseline, before the sugar solution is ingested, 
possibly due to their rather ubiquitous presence in food [28]. This challenges the sensitivity 
of the dual sugar test. It also resulted in the exclusion of one participant in the statistical 
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analysis of the PEANUTS Study described in chapter 5, which is highly undesirable. However, 
at this moment no better alternative is available. In next studies in which the sugar test is 
applied, it would be recommended to also standardize the meal(s) before the study test day, 
to minimalize high pre-ingestion levels. 
 
In general, the sugar test is a good way to functionally determine intestinal permeability, but 
standardized protocols are needed to be able to compare different studies with each other, 
a notion that is also emphasized in a recent review by Galipeau and Verdu [19]. 
Biomarkers of intestinal integrity 
Next to changes in intestinal permeability measured by alteration of sugar transport, several 
biomarkers have been proposed that reflect barrier integrity, which could also influence 
intestinal permeability. Two of such biomarkers are citrulline [29] and fatty acid binding 
protein-2 (FABP2)[30], which were included in our studies. 
 
FABP2 is considered a useful marker for the direct effects of an intervention on intestinal 
epithelial integrity [30-32]. The primary function of FABP2, however, is in the facilitation of 
intracellular fatty acid uptake and it has been studied in particular in relation to type 2 
diabetes [33]. The reason to consider this cytoplasmic protein as a biomarker of acute 
compromise in intestinal integrity is because i) it is exclusively and highly expressed in the 
small intestine [34], ii) it is a small (15kDa) protein relatively rapidly diffusing from the 
damaged epithelial cell into the blood stream when the intestinal epithelial cell is damaged 
[30], and iii) the half-life of this enzyme is relatively short (approximately 11 minutes) [35]. 
Many studies have indeed shown high specificity for FABP2 with small intestinal villus 
atrophy [30]. 
In our studies, however, FABP2 proved to be rather sensitive to mild stress situations as 
levels were relatively high at baseline compared to exercising values when participants 
arrived to the research setting on bicycle in fasted state (chapters 2 and 5). These high levels 
at baseline question the clinical relevance of using this protein as a biomarker for intestinal 
integrity with exercise challenges, mainly because endurance exercise had a minimal 
additive effect compared to the baseline values, at which point intestinal injury should be 
considered minimal. Next to this, not all participants were responders for FABP2, also shown 
by van Wijck et al. [36]. Taken this knowledge together, we would advise others to critically 
consider whether FABP2 is a sensitive enough and clinically relevant marker of exercise-
induced changes in intestinal integrity. If it is nevertheless decided to use FABP2, then it is 
important to let the participants rest sufficiently after arrival at the research setting and 
after insertion of the catheter. A rest of at least half an hour to become more relaxed is 
advised so that more reliable baseline values for FABP2 are obtained and small exercise-
induced effects may be more easily detected. 
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Citrulline is an interesting biomarker for lower enterocyte mass because the small intestine 
is the major source of citrulline production from glutamine, it is not incorporated in proteins, 
and release and uptake of citrulline by the liver are negligible [37]. In intestinal diseases with 
villous atrophy, such as Celiac Disease, or when individuals have less enterocyte mass due to 
a short bowel syndrome or partial resection of the small intestine, fasted citrulline levels in 
the blood have been shown to be lower than in healthy controls [29], but Peter et al. [38] 
indicated that a citrulline generation test, which consists of a challenge test with the intake 
of 20 grams of alanine-glutamine, could be a more sensitive tool to detect villous atrophy. 
These authors showed that fasted levels of citrulline did not differ, but the slope and iAUC of 
plasma citrulline after the alanine-glutamine challenge was much lower in patients than in 
healthy controls [38]. During the Protégé study similar observations were made after the 
intake of 40 grams of casein protein (chapter 2). When the protein was ingested directly 
after exercise, the increase in plasma citrulline levels was largely absent compared to the 
increase that is seen when the protein was ingested in rest [21]. It can be debated, however, 
whether levels of citrulline should also be considered a useful marker for acute exercise-
induced villous atrophy. In contrast, we hypothesized that lower plasma levels of citrulline 
after protein intake reflect lower enterocyte metabolic activity or capacity due to the energy 
depletion in the intestine during and directly after exercise rather than a decrease in 
absolute enterocyte mass due to villous atrophy [21]. For chronic conditions, citrulline may 
be a good marker for enterocyte mass, but for acute physical challenges such as endurance 
exercise, the use of systemic levels of citrulline may be of limited value in relation to 
intestinal integrity.  
Design of exercise challenges in human intervention studies 
There are at least three factors that should be taken into account when designing a human 
intervention trial in which an exercise challenge is included to induce intestinal permeability. 
Those will be discussed shortly below. 
First, the exercise protocol should be simple and effective. To this end, cycling is an 
endurance type of exercise which can be relatively easy standardized in a research setting 
and is therefore often chosen as an exercise intervention. My thesis research indicated that 
the exercise protocol does not need to be complicated to be effective. Even though it could 
have been partly the result of better timing of the sugar test, as discussed earlier, the simple 
protocol of one hour of cycling at 70% in less trained individuals resulted in a clear exercise-
induced increase in intestinal permeability, while the more complex dual cycling intervention 
with an overnight step in highly trained individuals, which were needed to complete the 
protocol, did not show such clear results. 
Second, it is preferred to have an exercise challenge that is as well relevant as feasible in 
different populations. It would be preferred to choose an exercise challenge which most 
different populations are able to complete. Cycling for one hour at 70% of their maximal 
workload is feasible for a group of healthy young individuals, but much less for a group of 
elderly or patients. It should be studied whether cycling at a lower workload and/or shorter 
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time would also result in relevant increases in intestinal permeability in different 
populations. In elderly, inducing intestinal permeability with an exercise challenge may be 
more difficult, because with a reduction in muscle mass and much lower workload, the 
reduction in splanchnic blood has been shown to be less pronounced [39]. 
Third, there are some factors to consider to standardize and control the intervention trial as 
much as possible. It is known from literature that the gut is ‘trainable’ when it comes to the 
ingestion of carbohydrates during and after exercise [40, 41], but not so much is known 
when it comes to the adaptation to exercise-induced permeability. Within the Protégé study, 
I determined the test-retest repeatability and found that intestinal permeability showed 
adaptation already upon a single retesting. This resulted in several hitches regarding the 
repeatability of the study and interpretation of the outcomes. It would be interesting to find 
out whether adaptation is also seen when a single exercise challenge is repeated, at 
different workloads, in different populations and with different intervals. Next, there could 
be any first-time-effect in highly trained individuals, which would suggest the need for a 
training session and possibly also strict standardization of exercise allowed to be performed 
by the participants in a certain time period prior to the study period. 
Intestinal permeability- The relation with energy metabolism 
Recently, the correlation between increased intestinal permeability and disease has caught 
the attention of the public and popular media, who persistently illustrate the leaky gut as an 
all-embracing cause of multiple diseases. This has led to a rise in acceptance of the diagnosis 
of a “leaky gut syndrome” and although so far not yet demonstrated, supporters of this 
diagnosis argue that repair of the intestinal epithelial barrier would cure underlying diseases. 
There are many different processes that are related to intestinal permeability and the 
function of the intestine in digestion and absorption of protein, as studied in this thesis, is 
only one of those processes.  
It would be fascinating to find out whether the observed increase in transport of dietary 
proteins induced by exercise corresponds with the transport of these proteins in specific 
intestinal diseases in which an increase in intestinal permeability is seen. This would 
substantiate the use of an exercise challenge in humans as a model to study and strengthen 
intestinal permeability in disease conditions.  
To support this at the mechanistic level, it would be also interesting to understand how 
induction of intestinal permeability by endurance exercise relates to mechanistic causes of 
intestinal permeability as observed in different diseases, such as Inflammatory Bowel 
Disease. In both cases, the deprivation of oxygen could be a causative factor, although 
induced in different ways.  
A lower supply of oxygen affects especially the intestine, as this organ is particularly sensitive 
to changes in oxygen supply. This is because the intestinal epithelium exists in a state of 
relative ‘physiological hypoxia’, already under normal physiological conditions [42-44]. 
Therefore small changes in oxygen supply can already lead to oxygen deprivation, which in 
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turn can result in mitochondrial ATP depletion. The hypoxic state of the intestinal epithelial 
cells is followed by an increase in intestinal permeability [45, 46].  
Exercise-induced blood redistribution is the most accepted hypothesis for the underlying 
mechanism of exercise-induced permeability [36, 47]. With this redistribution, more blood is 
directed to the muscles, while less blood is directed to the splanchnic organs, which results 
in a lower supply of oxygen and energy substrates. In Inflammatory Bowel Disease or other 
intestinal inflammatory diseases, on the other hand, an oxygen deficit can result from 
increased infiltration of innate immune cells, which also consume a considerable amount of 
oxygen [48]. Either way, both processes, exercise-induced changes in blood flow or 
increased oxygen demand due to inflammation, could result in an oxygen deficit. Together 
with a lower availability of energy substrate, this could lead to an energy-depleted state of 
the intestinal epithelial cells, which we hypothesize induces an increase in intestinal 
permeability.  
The process towards increased intestinal permeability is evidently a multifactorial one, but 
part of the mechanisms could be similar. In any case, more mechanistic studies have to be 
performed to elucidate the exact mechanism of intestinal permeability and how these can 
be affected by different physiological conditions. In my thesis research I used an in vitro 
Caco-2 cell model to study the mechanism of intestinal permeability and this will be 
discussed next. 
Lessons learned from in vitro studies - Methodological considerations for 
future study design 
In vitro Caco-2 model to study intestinal permeability 
In vivo human trials are a good way to characterise intestinal permeability in the context of 
the complete host system. It does not, however, offer many possibilities to study underlying 
mechanisms, unless biopsies are taken, but those are rather invasive and provide only snap-
shot information. Animal models with specific alterations in processes related to intestinal 
permeability, whether or not in combination with exercise, provide the possibility to 
investigate mechanisms while maintaining physiological complexity. However, as is the case 
for human studies, animal studies can be complex and time-consuming.  
Cell studies provide a further alternative. Although they lack the physiological complexity of 
the whole organism, cell models offer a high level of control and specificity which renders 
them very suitable for mechanistic studies and screening purposes.  
In this thesis, monolayers of the human intestinal cell line Caco-2 were used to examine the 
mechanism underlying exercise-induced permeability. In chapter 6 it was shown that 
mitochondrial inhibition resulted in increased permeability, which would substantiate a role 
for decreased oxygen supply in increased permeability as suggested in the previous 
paragraph. Chapter 6 also describes adaptations to the Caco-2 cell model which have been 
made to obtain a more in vivo-like situation to study intestinal permeability. Caco-2 
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monolayers that are grown on galactose medium switched to a more aerobic phenotype 
than those grown on glucose medium. This corroborates the in vivo situation, where 
intestinal cells are thought to depend on oxidative metabolism, based on high 
vascularisation and sensitivity for ischemia damage and ischemia/reperfusion damage [49].  
It would be interesting, and highly relevant, to compare the aerobic phenotype of cultured 
Caco-2 cells and human enterocytes, sampled by biopting, by analysis of mitochondrial 
respiration with respirometry (Oroboros or Seahorse) and by examining related mRNA and 
protein levels with qPCR and Western blot, respectively.  
 
Further improvement of the Caco-2 cell model developed during my PhD research could be 
made with regard to culturing conditions. One aspect is oxygen availability, which is much 
higher in routine culture than it actually is in vivo. The partial oxygen pressure in vivo at the 
serosal (basolateral) side of the intestinal epithelial cells lies around 60 mmHg [43, 50], while 
this is only half at the luminal (apical) side [43]. Studies with Caco-2 monolayers have shown 
that with routine culture, the partial oxygen pressure of the basolateral medium was around 
110 mmHg, which is almost double as seen in the in vivo situation [51]. The apical medium 
was not directly measured, but could be estimated to fluctuate around 50 mmHg, so also 
double as seen in the in vivo situation. It would be interesting to study the effect of lowering 
the supplied oxygen from 160 mmHg to a level that results in levels more similar to in vivo 
oxygen levels, but without inducing real hypoxia, on the aerobic phenotype of the Caco-2 
cell model and how this relates to intestinal permeability.  
An important aspect that is missing in the Caco-2 model developed in this thesis is the 
continuous mucus layer, which covers the intestinal epithelial cell monolayer and plays an 
essential role in intestinal permeability [52, 53]. Co-culture models with differentiated Caco-
2 intestinal epithelial cells and differentiated HT29-MTX mucus-producing goblet cells have 
therefore been suggested and developed, especially to study intestinal permeability to drugs 
and peptides [54, 55].  
 
There are furthermore several easily overlooked, but potentially essential factors that have 
to be taken into account during the study of intestinal permeability of Caco-2 monolayers. 
First is the large difference in effects that can be observed between proliferating Caco-2 cells 
and differentiated Caco-2 cells. First experiments on the effects of the complex I inhibitor 
rotenone on cellular ATP status were performed with proliferating Caco-2 cells, for which 24 
hours of treatment with levels of 20 nM was sufficient to induce cellular ATP depletion 
without affecting cell viability. In later experiments with differentiated Caco-2 monolayers, 
however, stimulation with rotenone did not show to have any significant effect on cellular 
energy status nor monolayer permeability unless the concentration was increased at least 5-
10 fold to 100-200 nM . Rotenone treatment with these high levels of rotenone, however, 
has major effects on cell viability of proliferating Caco-2 cells. This learned us that outcomes 
of titration experiments in proliferating Caco-2 cells are not always representative for 
differentiated Caco-2 monolayers. One explanation could be that energetic demands are 
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much higher during proliferation, and possibly also during differentiation, than during 
maintenance of the differentiated state of the Caco-2 cells monolayers. In our group, we 
more often observed that fully differentiated monolayers are much less responsive to 
different types of stimuli than those in earlier phases of monolayer differentiation 
(unpublished date). That is one reason to choose for a 14-day differentiation period for 
these experiments rather than the frequently used 21-day differentiation period, especially 
when Caco-2 cells are grown on galactose, because galactose seems to stimulate 
spontaneous Caco-2 differentiation.  
 
Another factor is the discrepancy in effects that can be observed with apical and basolateral 
treatment of Caco-2 cell monolayers. We observed large differences in one-sided treatment 
of Caco-2 monolayers with the complex inhibitors. Treating these monolayers with 200 nM 
of rotenone or Piericidin A on the apical side resulted in much lower responses than when 
applied on the basolateral side. One explanation could be that the apical membrane of the 
epithelial cells have more defence mechanisms than the basolateral membrane, because in 
vivo the apical membrane is also the first coming into contact with these compounds. 
Possible defence mechanisms include efflux pumps and ABC transporters [56, 57], to pump 
out potentially harmful substances. ABC transporters such as P-glycoprotein and breast 
cancer resistance protein are expressed on the apical membrane of the intestinal epithelial 
cells and can prevent the absorption of compounds into the body [58]. Furthermore, P-
glycoprotein- (Mdr1a-) deficient mice showed serious gastrointestinal problems, including 
spontaneous colitis and severe inflammation [59]. 
Implications and directions for future research 
My PhD project was part of the ‘IPOP Customized Nutrition research programme’, a 
programme that focused on global protein supply and the use of novel proteins in food and 
feed. This program arose from the prediction by the Food and Agriculture Organization of 
the United Nations (FAO) that the demand for animal-sourced foods will almost double 
between 2000 and 2030 due to the fast growth of the global population and changes in 
consumption patterns with an increase in urbanization in several parts of the world [60]. 
Within the ‘IPOP Customized Nutrition research programme’, knowledge was obtained to 
support possible solutions which may close the upcoming gap between the demand and 
supply of protein. In this quest, there is a strong focus on novel proteins derived from 
various sources such as plants, algae, food waste, and insects [61-63]. Next to the technical 
criteria, questions that arise from the field of novel proteins are directed at their potential 
effects on animal and human health, with respect to their digestibility and absorption [63], 
and their potency to activate the immune system [64]. This safety aspect is of particular 
importance as I have shown in chapters 2 and 5 of this thesis that changes in intestinal 
barrier function (e.g. increased permeability) under different physiological conditions can 
result in increased absorption of large molecules including protein fragments [21], which can 
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potentially induce an immune response. In my thesis I present possible ways to study 
intestinal permeability and underlying mechanisms, and the last part of this discussion I 
would like to dedicate to key steps that should be taken to test novel proteins with regard to 
digestion and absorption and implications of the models developed in my thesis research. 
 
The critical and perhaps most difficult step in the characterization of digestion and 
absorption is the detection of proteins and derived peptides that arise after digestion and 
absorption. Depending on the goal, different techniques are available, such as liquid 
chromatography-tandem mass spectrometry and enzyme-linked immunosorbent assay, with 
or without prior immunoprecipitation. It proves to be difficult to detect dietary peptides in 
the circulation and there can be several explanations for this.  
 
First, the levels of absorbed dietary proteins and peptides are very low, as reported in 
chapter 4 and 5 a peak level corresponding to about 0.0001% of the ingested peanut protein 
could be detected in plasma, and detection methods therefore need a very high specificity 
and sensitivity to correctly detect a dietary protein or derived peptide of interest, which is 
still a challenge [65, 66].  
 
Second, although an educated guess can be made based on in vitro experiments, it is often 
not exactly known which proteins and peptides are formed upon digestion in vivo. 
Heterogeneity in individual digestibility in combination with modifying factors, such as 
physiological or pathophysiological conditions, makes it very difficult to pinpoint on which 
protein or derived peptide should be focussed with regard to absorption into the circulation. 
As a starting point it could be a good idea to focus on peptides that are resistant to digestion 
in vitro. This is not only practical, but may be relevant as well, since bioactive peptides and 
allergens are indeed resistant to digestion [67]. Detection methods can then be developed 
that specifically target such peptides, as was reported here for Ara h 6 in chapter 4. If mass 
spectrometry is applied, the use of intrinsically labelled proteins could support the detection 
of small peptides with higher specificity in humans [68].  
 
Lastly, in chapter 4 it has also been described how endogenous immunoglobulin G (IgG) 
antibodies can interfere with an ELISA detection method, as the endogenous IgG antibody 
potentially blocks the binding epitope for the antibody used in the detection assay. This 
could truly underestimate the actual amount of the protein or peptide that is able to cross 
the intestinal epithelial barrier, and cause large variations in outcome between individuals. It 
is not yet clear against which peptides and protein we have these IgGs formed and what it 
exactly means. It has been stated that the levels of protein-specific IgG are not a valuable 
tool for diagnostics in the field of food allergies [69], but several studies do describe 
symptom improvement for migraine and IBD when they apply a diet in which foods are 
eliminated against which the patients have high levels of IgG [70-72]. With regard to the use 
and study of novel proteins, these IgGs should be factors taken into account. 
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To find out which digestion-resistant peptides are formed after digestion of novel proteins, a 
good in vitro digestion model is needed. This model needs to be reproducible and relevant 
to the in vivo situation. A harmonized protocol for the digestion of proteins has been 
developed within the INFOGEST COST action, in order to set up an in vivo relevant model for 
protein digestion [73], which could make future research better comparable with the use of 
the same protocol. The reproducibility in digestion outcomes of this harmonized protocol 
showed promising results compared to the digestion outcomes of protocols applied by 
different laboratories [74]. To increase its in vivo relevance, a more complex dynamic 
digestion model could be applied [75]. The model could possibly be further adapted by 
including the action of the brush border enzymes. This can be achieved by adding an 
incubation step with a solution of rat brush border peptidases, which is commercially 
available. This step is redundant when in vitro digestion is followed by an in vitro absorption 
model in which the brush border peptidases are included, such as a Caco-2 intestinal 
epithelial cell model.  
 
Once potential digestion-resistant peptides are determined and can be detected with high 
specificity and sensitivity, the next step in assessing the safety of novel food proteins is to 
study the digestion and absorption kinetics of these novel proteins in vitro and in vivo. 
The more physiologically relevant Caco-2 model described in chapter 6 could serve as an 
improved in vitro model to study intestinal permeability to novel proteins and derived 
peptides. This model can be further improved by implementing physiological oxygen 
conditions and increasing the cell layer complexity to mimic the intestine, for example, by 
co-culturing with mucus-secreting cells. Alternatively, other techniques, such as the ex vivo 
intestinal segment model, the Ussing chamber technique, or intestinal epithelial organoids 
can be used to mimic in vivo absorption [76-78].  
 
A next approach could be to study the digestion and absorption of novel proteins or derived 
peptides in vivo. In my thesis I presented a human intervention study in which an exercise 
challenge was included to study the effect of physiological challenges on intestinal 
permeability to dietary proteins and peptides (chapters 2 and 5). Several important aspects 
to consider when designing such intervention studies have been addressed in more detail in 
earlier parts of this discussion. This human intervention study, whether or not in 
combination with an exercise challenge, can be applied to study intestinal permeability to a 
broad range of novel proteins, provided that adequate detection methods for these proteins 
or derived peptides are developed. This human intervention study with exercise challenge 
can be used in future research in several directions. First, it would be highly interesting to 
study the underlying mechanisms of intestinal permeability on cellular level in vivo. Although 
pretty challenging with regard to practical feasibility, combining the exercise challenge with 
a small intestinal biopsy would offer the possibility to study in vivo the effect of exercise on 
morphology, tight junction protein levels and localization, and cellular metabolism. The 
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described human intervention with exercise challenge is also ideal to screen for the effects 
of a wide range of dietary compounds, so not only novel proteins, for improvement of 
intestinal permeability. The exercise challenge may show beneficial or deleterious effects of 
these dietary compounds which may not be detected when intestinal permeability is 
determined only in rest. This challenge furthermore fits very well in the new nutrition and 
health research field of ‘resilience’ or ‘phenotypic flexibility’ [79, 80]. 
Conclusions 
Overall, the observations as outlined in this thesis provide the evidence that the intestine is 
permeable to dietary proteins and peptides and that a widely experienced physiological 
challenge, exercise, enhances this permeability (chapters 2-5). Although correlations with 
several markers for intestinal permeability are indicated, we need to be careful to assign this 
observation to one or more of the potential causal factors: increased transcellular transport, 
decreased cellular integrity, or decreased intestinal barrier integrity (increased paracellular 
transport). More mechanistic studies are needed to pinpoint the underlying mechanism of 
increased intestinal permeability to dietary proteins and peptides following exercise. These 
mechanistic insights are crucial for correct interpretation of the data. 
Chapter 6 provides evidence that mitochondrial energy production may play an essential 
role in the maintenance of intestinal integrity. This mechanism could play an important role 
in exercise-induced intestinal permeability. A physiologically more relevant model has been 
developed to study intestinal permeability and underlying mechanisms, and future research 
could further improve and validate this model. 
 
Finally, the totality of the research presented in this thesis provides tools to study the 
potential health effects of novel proteins with regard to digestion and absorption, which is of 
importance in the search for alternative protein sources to close the predicted gap between 
global protein supply and demand.   
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The gut plays a pivotal role in human wellbeing by forming the body’s largest barrier 
between the external and internal environment. It has a major function in the digestion and 
absorption of nutrients and at the same time protects the body from the uptake of 
potentially harmful compounds. An increase in intestinal permeability could affect the 
uptake of larger fragments of food components such as partly undigested dietary proteins. 
Endurance exercise is a widely experienced physiological challenge known to increase 
intestinal permeability, but the subsequent effects on protein uptake are less studied. 
Furthermore, several underlying mechanisms for exercise-induced permeability have been 
hypothesized, but have not been substantiated. 
 
The aim of this thesis was to examine the effect of exercise intestinal permeability to dietary 
protein and peptides. Several in vivo proof-of-concept studies have been performed to study 
the effect of exercise on intestinal permeability towards small inert sugars versus small 
(casein-derived betacasomorphin-7) and large (peanut-derived allergen Ara h 6) dietary 
peptides. An in vitro model was developed to study one of the possible underlying 
mechanisms for an increase in intestinal permeability. 
 
Chapter 1 provides background on intestinal integrity and permeability and their role in 
digestion and absorption of dietary protein. Furthermore, the in vivo and in vitro models for 
intestinal permeability as applied in the next chapters are introduced. Additionally, the 
research aim and the outline of this thesis are presented. 
 
Chapters 2, 3, 4, and 5 describe in vivo findings on intestinal permeability. Chapters 2 and 3 
show findings of the Protégé study; this study consisted of 12 well-trained healthy young 
men who consumed a casein protein solution in rest or directly after completing a strenuous 
dual exercise protocol. 
Chapter 2 shows the effect of the strenuous exercise on urinary peptide excretion and 
markers of intestinal function and recovery, and inflammation. The exercise protocol 
resulted in increased urinary excretion of the casein-derived peptide betacasomorphin-7, 
even though intestinal permeability as measured with inert sugars was less pronounced. The 
exercise protocol also resulted in major changes in post-prandial amino acid profiles in 
plasma. It was concluded that strenuous exercise could have an effect on the amount of 
food-derived (bioactive) peptides crossing the epithelial barrier. In chapter 3 the test-retest 
repeatability of the outcomes of this strenuous exercise intervention is studied, since the 
complete intervention was performed twice in two separate weeks. It was shown that the 
metabolic effect parameters, such as glucose, lactate, and energy expenditure showed low 
test-retest variation, while stress response parameters to the exercise, such as creatine 
kinase, fibroblast growth factor 21 and intestinal permeability as measured with a 
lactulose/rhamnose challenge test showed high test-retest variation. It was concluded that 
even in well-trained young men an adapted response can be seen in exercise-induced stress 
after only a single repetition of the exercise intervention. This finding has implications for 
the design of human studies aiming at evaluating physiological responses to exercise.  
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In chapters 4 and 5, we focused on peanut protein instead of casein and compared to the 
Protégé study less trained individuals were included. These individuals reflect the general 
population level of training.  
Chapter 4 describes the PEANUTS Pilot study, which was performed to develop an ELISA 
method to detect the major peanut allergen Ara h 6 in serum after peanut consumption. 
This protein could not be detected in four out of ten tested individuals. It was shown with 
spiking experiments that high levels of Ara h 6-specific immunoglobulin G in the blood 
hampered the detection of this allergen. This may be a broader phenomenon in studies on 
the uptake of food allergens in the circulation, and may explain why variable levels of food 
allergen in serum have been reported in literature. In chapter 5 the developed ELISA 
detection method from chapter 4 is used in the PEANUTS Study. Potential participants were 
first screened for the ability to detect Ara h 6 in their serum by a spiking experiment. The 
PEANUTS study consisted of 10 untrained healthy young men and women who consumed a 
lactulose/rhamnose test solution and 100 grams of mildly-roasted unsalted peanuts. The 
first week consumption of the peanuts was followed by rest, the second week each of the 
participants had to cycle for 60 minutes at 70% of their maximal output directly after the 
consumption of the sugar solution and the peanuts. The endurance exercise significantly 
increased intestinal permeability (lactulose/rhamnose ratio) as well as the uptake of Ara h 6.  
The lactulose/rhamnose ratio and the levels of Ara h6 were strongly correlated. From this it 
was hypothesized that endurance exercise after food consumption leads to increased 
paracellular intestinal uptake of food proteins. However, increased permeability due to 
increased transcytosis or decreased cell integrity could also add to the observed increase in 
the protein uptake. 
 
Chapter 6 shows findings on the newly developed in vitro model for intestinal permeability. 
This chapter describes the development of an in vitro cell model mimicking to a higher 
extent the in vivo situation with regard to metabolic phenotype. The Caco-2 monolayers 
grown in galactose medium instead of glucose medium showed a more oxidative phenotype 
dependent on mitochondrial ATP production. Obstruction of this mitochondrial energy 
production resulted in decreased cellular ATP levels coinciding with increased monolayer 
permeability. Gene expression analysis of tight junction proteins was inconclusive, but 
pointed towards a defence mechanism of the Caco-2 cells during energy stress. It was 
concluded that mitochondrial functioning may be essential for maintaining a gut barrier 
function with high integrity. 
 
In chapter 7 the main findings of this thesis are discussed. Furthermore, several 
methodological considerations are made for future design of in vivo studies on intestinal 
permeability including an exercise challenge and in vitro studies on intestinal permeability 
with Caco-2 cells. Next, future implications of my research is placed in the context of the 
broader aim of the IPOP Customized Nutrition research program with regard to the health 
effects of novel proteins. Lastly, some general conclusions of my thesis research are drawn.
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